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Abstract 
This thesis summarises work done on the Escherichia coli strain MG1655 expressing a 
Green Fluorescent Protein (GFP) and the flavo-protein N-methyl-L-tryptophan oxidase 
(MTOX) product and examining the effect foreign protein production has on cell growth 
parameters. It also uses molecular modelling tools to generate data relating to FAD flux 
and MTOX production, comparable to that seen in E.coli fermentations. 
 
The MG1655 strain was chosen as it was the focus of the first K-12 complete sequencing 
project and closely related to the strain W3110, a second K strain that had been used to 
develop a number of deletion mutants which were central to the study. 
  
It presents data from shake flask and stirred tank reactor fermentations on minimal, 
carbon limited and complex media. Samples from these growth experiments were then 
analysed concentrating on biomass concentration, protein assays (both chemical and 
fluorimetric), high performance liquid chromatography and calculation of yield 
parameters. From this a baseline of growth was established with which to compare 
changes in growth after a shift in protein product from GFP to MTOX. An assay was also 
developed to measure the amount of active and inactive MTOX enzyme produced and 
this data compared with the level of FAD available to the cell at specific time points 
throughout growth. 
 
Finally modelling work is presented and in silico values compared with those generated 
in vitro. A discussion of the entire study concludes the work. 
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1.1. Project scope 
 
 
Escherichia coli is one of the most important hosts in modern day recombinant protein 
production. Throughout academia and industry its uses are widespread and with sequence 
data available for some of the most common strains of the bacteria it has been a favourite 
organism for many metabolic engineering and metabolic modelling projects in the past 
(Berry, 1996; Cameron, et al., 1997; Koffas, et al., 1999). The aim of this work was to 
investigate cofactor supply in an E.coli expression system producing the recombinant 
flavo – protein, N-methyl tryptophan oxidase (MTOX) and understand how strain 
alterations may affect the supply of FAD required for the activity of the protein product. 
A number of objectives were set throughout the course of the work which are stated in 
section 1.9 and discussed throughout the thesis. A discussion of all findings is presented 
in Chapter 7.  
 
Although there are drawbacks to using a prokaryotic expression system, such as the 
propensity for expressed protein to form insoluble inclusion bodies (González-
Montalbán, 2005), and even these inclusion bodies to cause cytotoxic effects in the host, 
dramatically reducing growth rate, (Carrio, 2006) they are still widely in use. In some 
cases the presence of these inclusion bodies can aid the downstream process by being far 
simpler to remove from the final cell harvest than proteins soluble in the cell. This, the 
ease of cultivation and the availability of well-established genetic manipulation 
techniques are often seen to outweigh the disadvantages. 
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The following work therefore outlines the construction and characterisation of a model 
system for the investigation of recombinant protein production in E.coli. It initially uses a 
plasmid construct expressing Green Fluorescent Protein (GFP) to act as a recombinant 
protein product with the benefits of being easy to visualise and measure as described in 
Chapter 2 (section 2.4.4) and also being designed to be inducible with IPTG. 
 
Therefore the first results chapter describes the characterisation of this strain/plasmid 
choice focusing on medium composition and comparisons between different minimal and 
complex media based on growth parameters including carbon uptake and acetate 
production in addition to the production of the recombinant protein, GFP. These 
parameters are investigated with the aim of establishing a baseline for bacterial growth 
and protein production that can be used in comparative studies with mutant E.coli strains 
or novel medium/regime changes. 
 
The second results chapter looks to build on the first but with the introduction of N-
Methyltryptophan oxidase (MTOX), a 42 kDa flavinated protein found in a range of 
organisms (Job et al., 2002) but with, as yet, no known function in E.coli. This decision 
was directed by the potential industrial applications, (discussed in section 1.6) of 
flavoproteins compared to GFP.  
 
An assay method was developed to measure the levels of both active and inactive enzyme 
(Hassan – Abdallah, 2005; Koyama, 1996) and applied to measure MTOX activity in 
samples taken at various points during culture growth. Also, an HPLC method was used 
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to measure levels of FAD throughout the fermentation (Barile, 1997) in an attempt to 
relate that information to measured MTOX activity. 
 
The final results chapter concentrates on the use and investigation of a metabolic model 
consisting of a reaction network developed originally by Edwards and Palsson (2000). 
The construction of metabolic networks and their use in metabolic engineering projects 
has been the focus of many research projects in recent years. Here data generated 
concerning FAD and MTOX flux and biomass production is compared to data generated 
from in vivo experiments. Similarities are seen, and explanations put forward where the 
model fails to accurately predict the experimental data. 
 
As a whole the experimental work sought to establish a model system for the study of 
recombinant protein production in, E.coli strains, evaluated the production of a 
flavoprotein and looked at the opportunities that allowed for rational metabolic 
engineering and also examined the possibility of in silico work to guide future 
investigations and understand the limitations of constraint- based metabolic modeling. 
 
 
1.2. Recombinant protein expression 
 
Over recent years there has been an explosion of interest in the use of micro-organisms 
and other cell-based systems for the production of biological products and small 
molecules. The list of recombinant proteins now routinely used in medicine is large and 
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seemingly ever growing. With more complex post-translational modifications compounds 
such as Kogenate® , a recombinant Factor VIII produced in BHK21 cells (Arnold, 1995), 
and Epogen®, an erythropoietin used for the treatment of anaemia caused by chronic 
kidney disease, produced in CHO cells (Yoon, 2001) are two of the many recombinant 
proteins produced in mammalian cell culture. Engerix B and Gene-Vac B (both 
recombinant Hepatitis B vaccines produced by GlaxoSmithKline (GSK) and the Institute  
of India respectively) and also a number of recombinant follicle stimulating hormones are 
produced in yeasts, (Shivananda, 2006).  
 
However, some of the most commonly used recombinant proteins, Humulin® and 
Humatrope® (Eli Lilly and Co.), forms of human insulin for the treatment of diabetics 
(FDA, 2003) and growth hormone (IGF-1), (Chen et al., 1995 and Cui et al., 2001) are 
produced in E. coli.. In fact E.coli is one of the most important production hosts in 
diabetic medicine with Pfizer producing an inhaled form of recombinant insulin known as 
“Exubera” and Sanofi Avensis producing a rapid acting insulin analoge using E.coli 
known as “Lantus”. 
 
Other examples can be cited such as the work done by Báez-Viveros et. al., (2004) using 
bacteria as a tool for the production of aromatic amino acids such as phenylalanine but 
these will not be discussed here. 
 
Some examples of this type of work often cite low yields, poor scalability, or simply 
insufficient commercial viability as problems facing the technology, (Frederick, et al. 
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2004; Hatfield, 2007); this can be seen in some ways as the root of this investigation. A 
better understanding of the relationships between the production of recombinant proteins, 
the host cell metabolism and related co-factors used for the activation of a protein product 
was a key aim throughout the entire project.  
 
Initial plans were to look at the strain MG1655 as it was also chosen for sequencing by 
Blattner’s group (Blattner et al., 1997) and is closely related to W3110, another K strain 
that has been used to develop deletion mutants in the E. coli genome, which were 
available for research (Mori et al., 2000). Certain mutants from this related strain could 
then be used to investigate how specific gene deletions altered carbon flux and other 
metabolic changes such as redox metabolism, to ultimately influence the production of 
active recombinant protein in the host. 
 
Understandably the field of recombinant protein production using many different hosts 
has been, and continues to be well researched. There are many avenues research has 
taken in recent years, which can be broadly grouped into 3 areas. 
 
Firstly much work has been done with very high – throughput or scale down methods, 
often based in 96 well plates. These have concentrated on vector/host interactions 
measuring growth parameters and protein production in a number of media, with 
numerous host organisms and differing recombinant protein vectors (e.g. Hewitt & 
McDonnell, 2004 and Braud, et al., 2005). Some others have set up protein arrays, 
investigating a smaller number of host/medium combinations but over a much larger 
Chapter 1:   Introduction  
 
 7 
group of possible recombinant proteins (Benita, et al., 2006). Scale down has been used 
to look more specifically at certain recombinant proteins and has attempted to understand 
methods for the optimization of protein production often in lab- scale continuous 
cultures, (e.g. Chae, et al., 2000 and Mahadevan & Doyle III 2003). Based on this work 
much research looks to scale up successful small – scale cultures often using modelling 
techniques to determine the behaviour of a culture at differing scales. This is obviously 
relevant for the commercial production of recombinant proteins but also acts as a useful 
tool to investigate and effects of differing oxygen and mass transfer at larger scales 
(Hatfield & Roth, 2007) 
 
Secondly, alterations in the host strains have been investigated for their impact on 
recombinant protein production. Although ease of the down-stream process is often not 
the concern of the fermentation scientist, there are a number of researchers interested in 
improving the expression of soluable recombinant proteins or conversely the ease of 
separation and activity of proteins forming inclusion bodies. Some workers have 
specifically looked into the up-regulation of chaperone proteins increasing the solubility 
and secretion of proteins and thus allowing less complex purification methods to be 
employed (Petersson, et al., 2004 and de Marco, 2007). Allied somewhat to this there are 
many groups investigating the folding of recombinant proteins expressed in bacteria, and 
even the possibility of glycosylation of protein products in bacterial hosts, something that 
has traditionally been seen as only easily achievable in mammalian cell culture (Baneyx, 
& Mujacic, 2004). 
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Finally the up-regulation of metabolic pathways to overproduce certain proteins or 
molecules is well researched. Where one protein of interest exists there may be scope for 
its overproduction or the overproduction of its precursors/cofactors that would improve 
yields and activity. The use of metabolic engineering for the overproduction of naturally 
occurring compounds such as riboflavin and folate (Burgess, et al., 2004) or L- valine 
(Kang, et al., 2007) is well documented.  
 
In context, the following work sought to design a semi-high throughput approach to 
determine the effect of plasmid and host cell on protein production in a number of E. coli 
strains. This needed to be robust enough to allow changes of medium, growth regime, 
plasmid construct and strain whilst generating comparable results. The initial model 
system was designed to express GFP under the lac promoter system control. As shown 
above, GFP has long been used to construct fusion proteins with less easily detected 
protein products and has been used successfully as an on line measure of their presence 
(Chae, et al., 2000). In the model system described in Chapter 4, GFP was used as the 
recombinant protein of interest.  
 
This system was altered in Chapter 5, expressing the solA gene product, N-methyl 
tryptophan oxidase (MTOX). The interest generally in flavoproteins and the reactions 
they catalyse is increasing and will be discussed later in this chapter (section 1.6) but with 
their wide range of reaction mechanisms and their dependence on the cofactor FAD for 
activity they made an interesting target for study. 
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Finally the work sought to use flux balance analysis (FBA) to investigate the relationship 
between carbon uptake rate and biomass accumulation, FAD flux and MTOX production. 
With this information a window of operation of active MTOX production was generated 
with the solution space defining the likely levels of all three variables assuming a 
constant carbon uptake rate. This data was compared with the experimental values in an 
attempt to see if modelling could be used to complement experimental work when 
looking at recombinant protein production. 
 
 
1.3. E.coli as a production host and other alternatives 
 
As mentioned in section 1.2 the growing number of therapeutic recombinant protein 
products utilise a variety of host systems. Which one is used often depends on a number 
of decisions including ease of culture, ease of purification of the final product, and what 
post-translational modifications are necessary for an active product. 
 
A list of the most commonly commercialised recombinant proteins shows a bias to a few 
expression sytems, namely, E. coli, Saccharomyces cerevisiae, murine cells, CHO cells 
or BHK21 cells, (Walsh, 2002) however there are many more available (Merten, et al., 
2001). Yeast species are being more widely used such as Kluyveromyces lactis and 
Hansenula polymorpha (Gad, 2007) over and above the common use of Pichia pastoris 
and S. cerevisiae, (Steinborn, et al., 2006) and other Gram positive and psychrophilic 
bacteria are becoming more widely used (Yang, et al., 2006 and Cusano, et al., 2006). 
There are also some cell free expression systems but these remain less well utilised, 
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mainly due to their cost compared to more commonly used expression systems (Endo, & 
Sawsaki, 2004). 
 
E. coli remains one of the most important expression systems in use currently. Through 
Blattner’s work (Blattner, et al., 1997) the full sequence of the K-12 strain MG1655 is 
known and with a long history of use in biotechnology the range of information and 
molecular biology tools available to the researcher is vast. 
 
Drawbacks commonly associated with the E.coli expression system have been the 
formation of insoluble inclusion bodies, (Ferrer-Miralles, et al., 2009) of recombinant 
protein expressed at high concentrations and the inability of prokaryotic cells to perform 
some post-translational modifications such as glycosylations, (Ferrer-Miralles, et al., 
2009). For these reasons mammalian cell culture has been used for many complex protein 
products; however these cultures are much slower growing requiring more specialist 
conditions and supplements than bacteria so are not ideal. Recently however work has 
been done to engineer E.coli giving it the ability to correctly fold and glycosylate a 
number of proteins, causing one researcher to state, “…guarantee that E. coli will remain 
an important host for the production of both commodity and high value added proteins.”, 
(Baneyx, & Mujacic, 2004). 
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1.4. Green Fluorescent Protein as a model system 
 
A number of the previously mentioned studies have investigated the production of 
recombinant proteins where no practical assay for the direct measurement of protein 
concentration or enzyme activity exists. In these cases it is common for a reporter gene to 
be spliced into the vector used to act as a signal when protein expression, of the reporter 
and also the recombinant target has occurred.  
 
Green Fluorescent Protein has been used extensively in this role (Chae, et al., 2000) but is 
used in work described here as a product itself. The ease of measurement and availability 
of commercial plasmid constructs made this an ideal protein to base the model system on 
for the initial section of study. 
 
GFP was isolated from the jellyfish Aequorea aequorea in 1962 (Shimomura et. al., 
1962) where it was found as a companion protein to aequorin, the well-known 
chemiluminescent protein of the same species. It was noticed that living A. aequorea 
tissue had an emission spectrum peaking at 508nm and looking green but pure aequorin 
peaked in the blue range, at 470nm (Tsien, 1998). This then led Shimomura’s group to 
discover GFP and suggest radiation-less energy transfer as the mechanism for exciting 
the protein. 
 
Its structure has been determined to consist of an 11 stranded β-barrel containing the 
chromophore made up of a single α helix as shown in Figure 1.1. 
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Figure 1.1) Protein structure of GFP (Source: Protein data bank) 
 
 
Its use as a tool in molecular biology was not realised until 1992 when Prasher reported 
the cloning and sequence of GFP (Prasher, et al., 1992). Since 1994 GFP has been used 
as a reporter protein (Chalfie et.al., 1994) flagging its own presence and therefore also 
proteins under the same control, by emitting green light (λem = 508 nm) upon excitation 
with near ultraviolet light (around 395 nm) or blue light (around 470 nm) (Ito et.al, 1999).  
Since then many mutations have been developed looking to improve the emission or to 
focus it to a single wavelength (Heim, et al., 1995) or to change the colour of the emitted 
light itself. Since the first mutations, blue, cyan and yellow fluorescent proteins have 
been developed as Figure 1. 2 displays. 
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Figure 1.2) San Diego beach scene created using various GFPs and the red-fluorescent 
coral protein dsRED (Source: Tsien laboratory, University of California)  
 
It was planned to use GFP not as a reporter as in many studies, signalling if a protein of 
interest was present or absent, or to determine a protein’s cellular location, but as a model 
protein product, easily detected, that could be studied with differing genomic 
backgrounds. GFP has been used in this way before and can be used as an online measure 
of recombinant protein production in batch fermentations (Chae, et al., 2000 and Chalfie, 
et al., 1994). 
 
A system was set up for recombinant protein expression, which will be described in 
Chapter 4. This also established a baseline for MG1655 growth parameters in the wild 
type and the plasmid carrying strain and allowed methods that would be used throughout 
the project to be developed. 
 
The plasmid construct was such that the GFP gene could be excised and the solA gene, 
(coding for the MTOX protein) inserted to allow for the continuation of the work into the 
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flavoprotein MTOX. The rational behind this planned change of recombinant protein is 
detailed below. 
 
 
1.5. The Keio collection: construction, history, and significance to the work 
 
An E.coli K-12 functional genomics project was initiated in Japan in the late 80s to 
provide further information into the organisation and control of the K-12 genome and to 
look at potentially developing a set of gene deletions of non essential genes and to 
attempt to determine the function of a number of unknown genes. The Kohara clones, a 
clone library describing the physical map of the entire E.coli genome, had been 
developed (Kohara, 1987) and after the publication of the K-12 sequence in 1997, 
(Blattner, et al., 1997) and the W3110 sequence in 2003 the Keio collection was 
constructed in 2005 (Baba, et al. 2006). 
 
The Keio collection contains a set of over 2000 precisely defined single gene deletions, 
of non-essential genes, in the E.coli strain BW25113 (a close relative to MG1655 and 
W3110). This was designed to provide a basic resource for systematic functional 
genomics but also as a data source for systems biology approaches and as such, allowed a 
number of gene targets to be chosen for investigation. 
 
The plan was to decide on a number of deletions that should affect metabolism, initially 
central metabolism but moving to riboflavin synthesis for the later work, and source the 
BW25113 mutant strains from Reading University (the UK depository for the Japanese 
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collection). After the development of the plasmid construct in MG1655 it would be a 
simple task to transform the BW25113 “wild type” and mutant strains to be able to 
investigate changes in their growth or protein production parameters. 
During the course of the initial work it became clear that the likelihood of single gene 
deletions fundamentally affecting the production of a recombinant protein in a bacterial 
cell was small. It has been shown that E. coli is relatively tolerant to the necessary 
changes in metabolic flux required to overexpress a certain desired product, e.g. pyruvate 
(Causey et.al. 2004), and it has a remarkable level of plasticity when altering the fluxes 
through what has been referred to as the high flux backbone (Almaas et.al., 2004). This 
finding suggest that only large scale, multiple deletions will have fundamental 
consequences on cellular carbon flux, whereas the effect of single gene deletions in 
central metabolism will be very small. It also has been shown that E. coli exhibits a high 
level of genetic epistasis and phenotypic plasticity which may well mask any effect of 
any single gene alterations in central metabolism (Remold and Lenski, 2004). Phenotypic 
plasticity is defined as an organisms ability to activate different phenotypes through the 
selective expression of specific genes in response to changes in the environment, 
(Agarwal, 2001). Genetic epistasis is an interaction between genes of an organism, in 
such that an effect on one locus can be altered or masked by effects on another, (Cordell, 
2002). This was thought to be a potential issue in that single gene deletion mutants may 
behave in very similar ways to the wild type organism simply because of the input of 
these two systems. As discussed in Section 1.7, it was thought that a number of deletion 
mutants in the riboflavin pathway may have a significant effect on carbon flux to make a 
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difference in the levels of riboflavin, FMN and FAD. This rationale was then the focus of 
mutant choice from the collection (see section 5.7 for details). 
 
1.6. MTOX: a cofactor dependent flavo protein. 
With this, more directed mutation approach in mind rather than searching for single, non-
lethal, gene deletions in central metabolism, and after discussions with GSK, the focus 
altered to another protein target, namely N-methyl tryptophan oxidase (MTOX).  
Active flavoenzymes have a flavin group covalently bound to them that alters the 
characteristics of their active site and conferring enzymatic activity (Hassan-Abdallah, 
2005). The suggestion was therefore, single gene deletions in the riboflavin pathway 
might have an effect on, not the expression of MTOX but the level of activity if FAD is 
in short supply or in excess. The fact that the riboflavin pathway is much less complex 
than central metabolism, although obviously in need of precursors from these pathways, 
made this goal seem attainable and also gave a much more defined system of reactions 
for application of in silico techniques such as flux balance analysis, covered in chapter 6. 
MTOX is a 42 kDa flavoprotein coded for by the gene solA (Swiss-Prot accession 
number P40874) with, as yet, unknown physiological function in E. coli. It catalyses the 
oxidative demethylation of N-methyl amino acids using oxygen as an electron acceptor 
(see Fig. 1.3). It is this reaction that allowed the use of the assay technique detailed in 
section 2.4.5 with the demethylation of N-methyl-L-tryptophan producing, among other 
compounds, hydrogen peroxide which can be detected in a colourimetric assay.  
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Figure 1.3) Reaction scheme catalysed by MTOX with the production of hydrogen 
peroxide 
 
One reason for using MTOX was that the group of flavinated proteins is large and 
possesses a number of possible commercial uses. There is obviously no commercial gain 
in increasing the level of Green Fluorescent Protein in a bacterial fermentation; however 
it provides an ideal model system to investigate metabolic pressures imposed by 
recombinant protein production. Flavinated enzymes however, have a number of 
suggested uses in the pharmaceutical and agrochemical industries. 
Bacterial sarcosine oxidases have been used for diagnostic measurement of creatinine in 
serum, in combination with creatininase and creatinase (Koyama, 1996) and 
flavoenzymes can be used in the biosynthesis of a relatively new group of antibiotics 
based on Nikkomycin (Venci, et al., 2002). These antimicrobials are potent inhibitors of 
chitin synthase (Venci, et al., 2002) and therefore find their uses as therapeutic antifungal 
agents (for the treatment of human conditions), but also easily degradable insecticides for 
the agriculture industry.  
Flavoenzymes have been linked with soil detoxification where aromatic compounds have 
been found to be broken down via hydroxylation catalysed by flavoenzymes (Massy, 
2000). These include many of the polycyclic aromatic hydrocarbon compounds often 
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found in oil spills or decommissioned industrial sites, which are known to have 
carcinogenic, mutagenic and teratogenic properties. Linked to this are the biocatalytic 
uses of flavoprotein monooxygenases in the desulferization of fossil fuels, (Gray et al., 
2003). The conventional chemical hydrodesulphurization process used often for diesel oil 
is not adequate for the complete removal of these compounds, (Berkel et al., 2006) 
however it has been shown that overexpression of a flavin reductase in E.coli and 
P.putida can greatly enhance the overall rate of desulphurization in these processes, 
(Galan et al., 2000). 
Flavoenzymes have also been seen to catalyse many of the same reactions known to be 
characteristic of cytochrome P450. These involve a diverse range of substrates and are 
generally the first step in the electron transport chain. Examples are seen in erythromycin 
biosyntheses and also in the first part of drug metabolism by the body where the action of 
cytochrome P450 has been shown to change the relative potency of the drug substance 
and could make a crucial difference in drug delivery and dosing. A striking catalytic 
feature of the P450 enzymes and other flavin-dependent monooxygenases is their ability 
to catalyse regioselective hydroxylations and entioselective sulfoxides, (Berkel, 2006). 
Regio – and/or enantioselective insertion of oxygen is not straightforward to be 
accomplished when using chemical techniques which makes the biocatalytic uses of flavo 
proteins even more attractive.  
Enantiopure styrene oxides are important building blocks for the pharmaceutical industry, 
(Panke et al., 1998) where different enantiomers of drug compounds can have wildly 
different effects in the body. An obvious example is that of Thalidomide where the R – 
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enantiomer is effective against the symptoms of morning sickness whereas the S – 
enantiomer has powerful teratogenic properties, (Stephens et al., 2000). Although in the 
thalidomide case the production of a single enantiomer would have little effect clinically 
as the two forms readily interconvert in vivo, (Stephens et al., 2000) for other compounds 
this may be an important part of their production and commercialisation. 
From all the flavoprotein monooxygenases the group known as Baeyer – Villiger 
monooxygenases have been studied extensively for their wide range of usable substrates 
and, as described above, their enantio and regioselectivity, (Berkel et al., 2006). Recently 
a new flavin dependent biocatalyst was discovered known as phenylacetone 
monooxygenase which has been shown to be both thermo stable and tolerant towards 
solvents, (Fraaije et al., 2005). Biocatalytic conversions using previously discovered 
BVMOs are often hampered by their instability so this is an important discovery which 
may further expand the uses of these enzymes. 
Finally, flavoproteins have been linked with bioluminescence in many organisms, 
phototropism in plants, nucleic acid repair in prokaryotic and eukaryotic cells and also in 
programmed cell death (apoptosis) (Petushkov, & Lee, 1997; Christie et al., 1998; 
Massey, et al., 2000; Naudi, et al., 2007). It is easy then, to see why there is much interest 
in these cofactor requiring enzymes in the above fields and other areas, such as 
biotransformation, resulting in a strong reason for studying this area. 
As shown, various flavinated proteins may have valuable uses and this study looks to 
understand alterations in the pathways producing their common cofactor, FAD. Although 
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MTOX will be the focus of the work, the knowledge gained on cofactor metabolism 
should be relevant for other members of the group. 
 
1.7. Riboflavin pathway and genes of interest 
 
 
To be able to determine which deletion mutants in the Keio collection (Baba, et al, 2006) 
had the potential to impact MTOX activity via FAD flux, the riboflavin pathway was 
examined (Figure 1.4).  
 
Referring to the pathway there are 5 obvious genes that may have a direct impact on 
riboflavin production and linked to that, both FMN and FAD production.  
 
The gene ribC codes for the enzyme riboflavin synthase transferring an alkyl group from 
6,7-Dimethyl-8-(1-D-ribityl)lumazine and producing riboflavin as one of the resultant 
compounds. It was obvious that a deletion mutant without this enzyme would prove lethal 
as the flux to riboflavin would be curtailed. Thus this mutant was also not included in the 
Keio collection. 
 
Therefore the next gene in the pathway to riboflavin was investigated; ribF codes in the 
majority of prokaryotes for a bifunctional flavin kinase (Martinez – Julvez, et al., 2003) 
occasionally occurring as a monofunctional FAD synthetase but this function is more 
common in eukaryotic cells than prokaryotes (Solovieva, 2003). In E.coli K-12 W3110 
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this enzyme catalyses the conversion of riboflavin to FMN utilising ATP and 
subsequently the conversion of FMN to FAD, again using phosphate from ATP, is 
catalysed. Although it would be interesting to see the effects of up-regulation of this gene 
(see Chapter 7) it again was clear that a deletion in ribF would cause a cessation in FAD 
and FMN production. These two cofactors play such key roles in areas such as 
mitochondrial electron transport, fatty-acid oxidation, and metabolism of vitamin B6, 
vitamin B12 and folates, (Kearney, 1952) that a deletion mutant would be lethal. 
 
The two genes downstream of riboflavin cobB and cobT both coding for 5, 6, - 
dimethylbenzimidazole phosphoribosyltransferase and catalyzing the reaction of beta-
nicotinate D-ribonucleotide + 5,6-dimethylbenzimidazole to nicotinate + alpha-ribazole 
5'-phosphate were considered as possible targets. 
 
Another possible target for mutation was thought to be appA, coding a phosphoanhydride 
phosphorylase and catalyzing the non-reversible conversion of FMN to riboflavin with a 
phosphate being donated to ADP to form ATP. Very little information is available in the 
literature about the rate of back conversion from FMN to riboflavin facilitated by appA 
and it is not included in Palssons reaction network that is used as the basis for the 
modeling work described in chapter 6. Although cobT and cobB are included no mention 
is made of appA. 
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Figure 1.4) Detail of the Riboflavin pathway showing genes of interest for FAD 
production in E. coli K12 (Source: Kegg Database) 
 
  
As non-lethal mutants, appA, cobB and cobT were contained in the Keio collection and 
available for use. It was thought that potentially removing appA may reduce the back 
conversion of FAD to FMN and therefore result in an accumulation of FAD. cobT and 
cobB are known to work in tandem (Chen, et al, 1995) therefore whilst removing both 
would prove lethal to the host, stopping production of vitamin B12, a deletion of either 
one would probably reduce, but not stop, the flux downstream of riboflavin. Again the 
hypothesis was that a ‘constriction’ in the pathways downstream of riboflavin may cause 
an accumulation of riboflavin and FMN/FAD levels may rise as a consequence of this. 
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Further rationale behind the deletion choices is included in chapter 5 (section 5.11) where 
a discussion of the results gained from each mutant strain is also found. 
 
1.8. Constraint-based metabolic modelling 
 
 
The construction of in silico models has allowed the interpretation of a flood of genomic, 
transcriptomic, and other data generated in high-throughput experiments. The use of 
these models allows an insight in to large amounts of complex data and can be used to 
place that information in the wider context of cellular physiology (Reed & Palsson, 
2003). 
 
Models have been constructed using kinetic information, cybernetic methods, stochastic 
models or those based on biochemical systems theory but none have proved as robust or 
grown to such size as many constraint based systems (Reed & Palsson, 2003). Relevant 
to the planned work is the history of using constraint based metabolic modelling to 
predict changes in metabolic flux of gene knockouts or deletion mutant often compared 
to the parent strain (Segre, et al, 2002). 
 
The flux balance analysis (FBA) method has been developed in the light of the explosion 
of “-omics” data over the last few decades. It can be used to assess the capabilities and 
systemic properties of a metabolic genotype (Edwards and Palsson, 1999), and at its heart 
relies on achieving a steady state mass balance for a defined number of metabolic 
reactions.  
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FBA methods only require information about metabolic reaction stoichiometry, metabolic 
requirements for growth and potentially strain specific parameters such as seen in this 
study with the production of GFP and MTOX. This information determines a domain of 
stoichometrically allowable flux distributions that can define a strain’s, “metabolic 
genotype” (Varma and Palsson, 1994), this genotype can be further constrained where 
additional kinetic or regulatory information is available. 
 
Also relevant to the planned study, E. coli has been the focus of many early and 
developing constraint based models which has then broadened to organisms such as 
Helicobacter pylori, Streptomyces coelicolor and the industrially important, 
Saccharomyces cerevisiae. (Edwards, et al, 2002; Borodina, et al, 2005 and Förster, et al, 
2003) 
 
As a comparison, kinetic based models can give a very detailed understanding of 
metabolic processes but are often limited by the amount of specific information available. 
Constraint based modelling however, does not attempt to define one single solution for a 
set of governing equations, rather calculating a collection of allowable solutions that 
ultimately define a solution space. This can then be further reduced with the imposition 
of greater constraints such as mass balance, stochiometric information, regulation of the 
enzymatic reactions concerned and details of enzymatic capacity (with appropriate Vmax 
data) (Bonarius et al, 1997). 
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The solution space can be further defined and reduced in size using a number of different 
techniques. These are better described in Figure 1.5 but include extreme pathway 
analysis, where the edges of the solution space are used to define extremes in metabolic 
behaviour and phenotypic phase plane showing what conditions the network operates 
under different limitations.  
 
 
 
Figure 1.5) Constraint based modelling: Application of constraints to reduce the 
previously defined solution space in which a cells network must operate, (Source: Reed 
and Palsson, 2003)  
 
 
The effect of gene deletions can be computed which is further explored in Chapter 6, and 
finally linear optimisation can be used to find optimal conditions (allowing the definition 
of optimal yield of products or optimal biomass accumulation as has been attempted 
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again in Chapter 6) this is often referred to as flux balance analysis (Varma and Palsson, 
1994). In this chanpter both gene deletions and linear optimization were used to shrink 
the potential solution space with constraints of FAD and MTOX production and 
maximum specific growth rate.  
 
 
1.9. Aims of the work and layout of thesis 
 
The following work is organised into 4 main results chapters 3 – 6 which describe the 
development of a number of methods used in the project, experimental results from the 
GFP construct, the MTOX producing strain and the modelling work respectively. These 
chapters are supplemented by chapter 2 which describes the methods used in the study 
and finally chapter 7 which gives a general discussion of the work as a whole and 
attempts to place the study in current context.  
 
The aim of the work as a whole was to investigate flavin cofactor supply in a system 
expressing a recombinant flavo-protein and to understand how different strains and/or 
mutations may affect the supply of FAD and subsequently the activity of the recombinant 
protein product. Following this aim a number of experimental objectives were 
considered: 
 
• To develop a model system in E. coli for the controlled expression of GFP with 
the potential to apply it for other proteins 
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• To establish a protocol and develop methods for comparable, growth and 
recombinant protein production in a variety of E. coli host strains, with a variety 
of plasmid constructs and the potential for a semi-high throughput method 
• To engineer the same plasmid construct used for GFP production for the 
expression of N-methyl – l – tryptophan oxidase and develop a reliable assay for 
both active and inactive forms of the expressed enzyme 
• To measure FAD, riboflavin and FMN levels at certain points in fermentations 
and relate this information to MTOX activity levels 
• To model the test system using Palsson’s E .coli reaction network, altered for the 
strains used and for MTOX production, and compare values generated with 
experimentally data. 
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2.1. Introduction 
 
The following chapter outlines methods used throughout the study. It initially 
concentrates on the approach used to characterise growth of E. coli strains and the 
media chosen. It goes on to explain the analytical methods used for the measurement 
of cellular products and metabolites. It covers statistical analysis of data sets, which 
are used throughout the work and explains the background of modelling software 
used to generate a metabolic model of E.coli for use throughout chapter 6. 
 
2.2. Microorganisms used and cultivation methods 
 
2.2.1. Selection of host strains  
 
After initial experiments with MG1655, 3 additional strains were used for the 
continuation of the work all four strains and their respective mutations from the E. 
coli wild type (Source: CGSC website (http://cgsc2.biology.yale.edu/index.php)) are 
shown in Table 2.1. 
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Table 2.1) E.coli strains with genotypes used in the study (Source: CGSC website, 
http://cgsc2.biology.yale.edu/index.php) 
 
 
E. coli K-12 MG1655 was chosen as the initial host strain having been obtained 
from the American Type Culture Collection (ATCC no. 47076). This was used as it 
formed the basis of the first E.coli full genome sequence completed, (Blattner et.al., 
1997) and was also the basis of the metabolic model being developed in house. 
 
TG1 was provided by GSK as it was the optimised strain for the production of the 
recombinant proteins, (see section 5.1) and as such was the only non K-12 strain to 
be included in the study. 
 
W3110 was used as it is very closely related to MG1655 but also as it was the 
starting point for the Keio collection of mutants, (Mori, 2000; Baba, et al., 2004 & 
2006). This was mutated into BW25113 before undergoing further alterations to 
produce the numerous Mori single gene deletion mutants available. 
  
The table above clearly shows the relationship between the first 3 strains, which are 
all used in the mutation work (covered in Chapter 5, section 5.7). It also underlines 
the difference between the K-12 strains and GSK’s production strain TG1. 
Strain Genotype 
MG1655: F- LAM- rph-1 
W3110: F- LAM- rph-1 In(rrnD-rrnE) 
BW25113: F
- LAM- rph-1 DE(araD-araB)567 lacZ4787 (del) (::rrnB-3) DE(rhaD-
rhaB)568 hsdR514 
TG1: F’ traD36 laclq ∆(lacZ) M15 proA
+B+/supE ∆(hsdM-mcrB) 5 (rk- mk+ mcrB-) 
∆(lac-proAB) 
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2.2.2. Cell bank preparation 
 
The original stocks were streaked out on nutrient broth (Oxoid #2, Oxoid/Fischer 
Scientific UK) with agar added at 1.2 g/L giving a solid nutrient medium. These 
were grown overnight at 37oC. A single colony was then transferred to a fresh plate 
and incubated again overnight at 37oC. Using 3.5mL of 20% (v/v) glycerol and a 
sterile glass rod, cells were removed from the surface of the agar plate and the 
resulting suspension transferred, using a sterile pipette, into small aliquots stored at -
80oC. This constituted the master cell bank (MCB). For further experiments a 
working cell bank (WCB) was produced by taking a number of colonies from the 
MCB using a sterile loop and streaking them onto plates, incubating overnight at 
37oC, and again preparing glycerol stocks to store frozen. 
 
After the construction of plasmid carrying strains (puvGFP, pMEX8, as described in 
section 2.3) the same protocol was used for the preparation of bacterial stocks and 
cells frozen at -80oC for storage. 
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2.2.3. Media preparation  
For all fermentation experiments, E. coli was grown initially from the WCB on 
plates of nutrient broth agar (as described in section 2.2.2) or nutrient agar (Oxoid).  
 
After the initial overnight growth a single colony was transferred into M9 or M6 
minimal media (see Table 2.2 and 2.3), or Luria Bertani broth (LB) with the addition 
of 4% (w/v) glucose for the liquid cultures. M9 was made up of four components: - 
M9 salts, prepared as a 10x stock solution (pH 6.95), and calcium, magnesium salts 
and glucose, as a 100x solution. These were autoclaved separately (121oC for 15 min 
(Denly Autoclave)) and then could be stored on the bench for future use.  
 
 
Table 2.2) M9 medium composition  
 
 
 
M6 medium was made up of five different components. Similarly to M9, a salt 
solution was made up to a 2x stock (any higher concentration proved difficult to 
adjust the pH effectively) pH 6.95. Again the magnesium and calcium salts were 
added separately for the same reasons as above. Glucose was added from a 100x 
Component Stock Concentration  (g/L) 
Working Concentration 
(g/L) 
M9 Salts 
Na2PO4.7H2O 
KH2PO4 
NaCl 
NH4Cl 
Glucose 
CaCl2 
MgSO4.7H2O 
152.00 
30.00 
5.00 
10.00 
400.00 
1.47 
24.64 
15.20 
3.00 
0.50 
1.00 
4.00 
0.02 
0.25 
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stock. Finally a 100x of trace elements was prepared. This concentration was used to 
enable accurate quantities of constituents in low concentrations. 
 
Table 2.3) M6 medium composition  
Component 
Stock Concentration 
(g/L) 
 
 
 (g/l) 
Working Concentration 
(g/L) 
M6 Salts 
(NH4)2SO4 10.4 5.2 
NaH2PO4 7.72 3.86 
KCL 8.05 4.025 
MgSO4 104 1.04 
Citric Acid 8.32 4.16 
CaCl2 25 0.25 
Glucose 400 4 
TRACE ELEMENTS 100x Stock solution 
Citric acid 104 1.04 
CaCl2 5.22 0.05 
ZnSO4 2.06 0.02 
MnSO4 2.72 0.03 
CuSO4 0.81 8.0x10-3 
CoSO4 0.42 4.0x10-3 
FeCl3 10.06 0.10 
H3BO3 0.03 3.0x10-4 
NaMoO4 0.02 2.0x10-4 
 
 
LB broth is made up of 10 g/L tryptone, 5 g/L yeast extract and 10 g/L NaCl, 
however this was available as a premixed powder from Oxoid. 
 
Antibiotics, where necessary were made up to working concentrations, sterile 
filtered, aliquoted into single use volumes and stored at -20ºC until needed. 
Ampicillin stocks were made up to 50mg/mL and used at 500µg/mL for solid media 
or 300µg/mL for liquid culture. Kanamycin was made up to a working concentration 
of 37.5mg/mL and used at 30µg/mL for all media. Plasmid induction was enabled 
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through the addition of IPTG which was made up as a stock concentration of 
200mg/mL and used to a final concentration of 1mM (238 mg/L) for all 
experiments. 
 
2.2.4. Shake flask fermentation experiments 
 
Initial shake flask fermentations were carried out in 2L baffled vessels however the 
size of these was unnecessary for the planned work and made large numbers of 
replicates inconvenient.  
 
The seed train was essentially similar for the shake flask experiments and the stirred 
tank reactors, however the scales were obviously altered for the larger cultures. A 
single colony was picked from an overnight plate cultured from the working cell 
bank and was used to inoculate 2.5mL of medium in a 25mL Universal tube, this 
was then grown overnight at 37oC in an orbital shaker (200rpm, 5cm throw, New 
Brunswick Scientific, Co., Inc., USA). At the start of the experiment this inocculum 
was added to 22.5mL fresh medium in a pre-sterilised 250mL baffled shake flask 
and returned to the shaker at 37oC. Samples were taken every hour for a period of 8 
hours, and then left overnight for a final 24h reading. To lessen the effect of 
diminishing culture volume sample volumes were either 100µL (for samples 
analysed for optical density and fluorescence only) or 1mL (where the sample 
needed to be lysed for further analysis) at alternate hours. 
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2.2.5. 5L stirred tank bioreactor experiments 
 
Larger volume fermentations were run using a pair of 7L reactors (New Brunswick, 
New Brunswick Scientific Co., Inc., USA) with an operating volume of 5L. The 
bioreactors were of glass construction with stainless steel head plates containing the 
ports used for sterile additions. The vessels were filled with the appropriate amount 
of RO (reverse osmosis) water prior to heat sterilisation. The DOT, pH and 
temperature were monitored by Ingold electrodes (Ingold, Switzerland), linked to 
real time data acquisition system (RT-DAS) (Acquisitions Systems, Reading UK). 
Off gas concentrations of oxygen, nitrogen, carbon and argon were monitored by 
mass spectroscopy, (Fisons Scientific Instruments, Prima 600) and parameters such 
as oxygen uptake rate (OUR), carbon dioxide emission rate (CER) an respiratory 
quotient (RQ) were calculated.  The vessels that would be used for the addition of 
acid, base, media components and inocula were sterilised alongside the main vessel. 
Post-sterilisation, media components were added via sterile transfer and finally the 
inoculum. The fermentations were then run at 37oC with an airflow rate of 1.5vvm 
and an agitation rate of 500rpm. Polypropylene glycol (PPG) was added as antifoam 
at 4mL/L if required.  
 
The fermentation was monitored remotely and automatic pH control, to 7, was 
achieved with the addition of 2M NaOH and 2M H2SO4. Off gas from the foam trap 
was filtered through a 2µm filter before entry into the mass spectrometer.  
Chapter 2:   Materials and Methods  
 36 
Sampling of the fermentations was carried out every hour with a 4mL sample taken 
from the aseptic sample port and line. 
 
2.2.6. Sample preparation for HPLC analysis 
 
Samples from shake flask or stirred tank reactor destined for HPLC analysis of FAD, 
FMN and Riboflavin levels (see section 2.5) were quenched using perchloric acid to 
“freeze” all cellular metabolic activity at the point of sampling (Vinkler, et al., 
1978). For shake flask fermentations 0.2mL of 1.6M HClO4 was added to sterile 
Eppendorf tubes and 1mL of sample added to the tubes upon sampling. For stirred 
tank reactors 0.8mL of 1.6M HClO4 was added to sterile universal tubes and 4mL of 
sample collected directly into the prepared tubes. For each case, 1 minute after 
quenching the equivalent volume of 10M KOH + 0.25M Tris was added to 
neutralise the solution. After neutralisation samples were stored at 4ºC, protected 
from light for no longer than 24 hours before lysis and further analysis. 
 
2.2.7. Cell lysis 
 
Bacterial lysis was carried out via sonication (Soniprep150, Sanyo, Japan) in lysis 
buffer (10mM Na2PO4, 1mM EDTA, 10mM MgCl2) (Feliu et al., 1997).  
 
Cells were pelleted (10min, 16500 x g, 4°C), washed twice with 1mL sonication 
buffer and resuspended in a further 1mL buffer. Sonication was carried out, on ice, 
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for 10 s at 8 kHz. These conditions were determined in experiments carried out and 
described in chapter 3 section 3.2. 
 
Cell debris was removed where necessary by a further centrifugation step (10min, 
16500 x g, 4°C) to produce a clarified cell lycate. 
 
2.3. Plasmid construction 
 
The initial plasmid construct was uvGFP (Green Fluorescent Protein optimised for a 
high UV signal) (BD Biosciences) incorporated into a pBR322 type plasmid. The 
construct had an ampicillin resistance gene to allow selection and control of 
induction was sought with the inclusion of the lac repressor. A map of the original 
plasmid is shown in Fig. 2.1. 
 
Figure 2.1) Plasmid map of original GFP construct (Clontech) 
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The multiple cloning sites (MCS) allowed the easy removal of the GFP gene if 
required 
 
Once the focus of the work moved to the MTOX protein (see Chapter 5), solA (gene 
coding for N-Methyltryptophan oxidase) was sourced by Prof. John Ward and 
amplified using PCR and the primers below, based on the published data (Gene 
Bank accession number EG12669).  
 
N-terminus: 
5’ AAGCTTATAAGGAGATATACATATGAAATACGATCTCATCAT 3’ 
   Hind III    Ribosome 
     binding site  
 
C-terminus: 
5’ GAATTCTTATTGGAAGCGGGAAAGC 3’ 
    EcoR1 
 
The PCR product was then incorporated into pCR®2.1-TOPO® cloning vector 
(Figure 2.2)  (Invitrogen) and transformants (for method see page 41) plated onto 
selective AMP, Xgal, IPTG plates. These were grown overnight and white colonies 
picked for further work. 
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Figure 2.2) Plasmid map for the pCR®2.1-TOPO cloning vector 
 
 
Plasmid DNA purification was then carried out using the QIAprep Spin Miniprep 
Kit (Qiagen, UK) according to the manufacturer’s instructions. Plasmid DNA was 
eluted into TE buffer (10 mM Tris-HCL (pH 7.5), 1 mM Na2EDTA), and stored at -
20°C. Restriction digests of the resulting DNA were carried out with EcoR1 and 
HindIII.  
 
Digestion of plasmid DNA with restriction endonucleases was performed using 
enzymes from New England Biolabs. Typically 10µL plasmid DNA was digested in 
a total volume of 20µL, comprising 1µL restriction enzyme, 2µL 10X restriction 
buffer and 7µL TE buffer. The solution was then incubated at 37°C for 2-3 hours. 
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The rationale behind the digests was that a 1200bp fragment would be seen on a gel 
from a HindIII digest if the PCR product had incorporated into the cloning vector 
with the correct orientation. A 60bp fragment would indicate incorrect alignment. 
With the EcoR1 digest a 1200bp fragment would be seen if solA was present, 
nothing if not. 
 
As a final check plasmid DNA was purified and quantified using the Picogreen 
assay (Labarca, 1980) and then sent for sequencing to verify the construct was 
correctly aligned. (Data not shown) 
 
Once these were confirmed minipreps were again done for the TOPO clone and the 
GFP carrying strain. Restriction digests were again completed with a mix of EcoR1 
and HindIII to release the inserts from each plasmid. Competent cells of E. coli 
MG1655 and W3110 were prepared following a protocol provided by Prof. John 
Ward.  Briefly this consisted of a 5mL overnight culture of MG1655 and W3110 in 
nutrient broth transferred to 20mL of fresh broth containing 20mM MgCl2. This was 
grown for one hour and then spun down at 7000 x g , 10min, 4oC and kept on ice. 
 
The pellet was then resuspended in 2mL of ice cold, sterile 75mM CaCl2, 15% (v/v) 
glycerol, aliquoted into 200µL amounts and stored at -80oC until needed. 
 
From the digest of the TOPO clone a gel was run (see figure 2.3), the band for the 
solA gene excised from the gel and an extraction protocol (Qiagen) completed to 
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release the DNA. The expression vector was then heat inactivated for 10min at 70oC 
before being mixed with the MTOX fragment, T4 buffer, (50 mM Tris-HCl, 10mM 
MgCl2  , 1mM ATP and 1mM Dithiothreitol) and 1µL T4 ligase in a 20µL rection 
and stored at 16oC overnight for the ligation to occur. 
   
 
   
 
Figure 2.3) Digest of MTOX TOPO clone showing band for excision 
 
Key: 
Lane 1: GFP plasmid 
Lane 2: λ PST marker (bands visible =11490, 5777, 4749, 2888bp) 
Lane 3: TOPO digest with solA gene insert 
Lane 4: Low molecular weight ladder (BioRad) 
Lane 5: Mass ruler (BioRad) (bands visible = 10000, 9000, 8000, 7000, 6000, 5000, 
    3000, 1000, 500, 400, 300, 200, 100bp) 
Lane 6: Gene ruler (BioRad) (bands visible = 5000, 3000, 2000, 1500, 1000, 500,  
    400, 300, 200, 100bp 
 
solA 
gene 
insert 
Lanes:   1   2     3   4    5    6  
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The final stage of the process was to mix the ligated DNA with an aliquot of 
transformed cells and again follow a protocol suggested by Dr Ward. After this stage 
cells were plated out and 8 samples taken for a final miniprep. This step was again 
digested with EcoR1 and HindIII before being run on a gel to confirm the correct 
insert had been ligated into our host. (results not shown) 
 
All plasmids used including the pQR constructs generated during this work are 
summarised in Table 2.4. 
 
Table 2.4) Plasmid used in this study and its characteristics 
Plasmid (size in kb) Characteristics Source 
pGFPuv (3.3 kb) LacZ Apr Invitrogen, UK 
pMEX8 (5.7 kb) LacZ Kmr Dr Chris Preston GSK, UK 
pQR497 (5.0 kb) solA in TOPO 2.1 Ward (unpublished) 
pQR498 (3.6 kb) solA in pGFPuv Apr (GFPuv excised) This study 
Abbreviations: Apr, ampicillin; Kmr, kanamycin; kb, kilobase 
 
 
 
2.4. Analytical methods 
 
 
2.4.1. Optical Density 
 
 
As a measurement of cellular growth the optical density of the broth at 600nm was 
measured using a spectrophotometer (Cecil Aquarius 7000, Cecil Instruments UK). 
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After taking a sample from either shake flask or fermenter, the sample was 
immediately placed on ice and the absorbance read at 600nm against a blank of 
sterile media. The data obtained, in conjunction with dry cell weight (see below) 
could then be used to generate growth profiles of the cultures and calculate 
important growth parameters such as the maximum specific growth rate (µmax) and 
conversion yield on glucose (Y x/glu). Maximum biomass concentration (Xmax) was 
determined by referring to an OD/DCW correlation (Section 2.4.2) 
 
2.4.2. Biomass correlation 
 
Part of the early work sought to develop a reliable correlation between optical 
density (OD, 600nm) and dry cell weight (DCW, g/L) to enable the calculations 
described above to be performed. After OD measurements had been taken, 1mL 
duplicates were made and added to pre-weighed, pre-dried (90oC for 24h) eppendorf 
tubes. These were placed in a microfuge (Biofuge 13, Heraeus, Germany) at 17900 x 
g for 10min. Supernatant was transferred into clean eppendorf tubes and stored at -
20oC for future analysis. The cell pellets were then resuspended in RO water and 
centrifuged once again. The supernatant was discarded and the walls of the tube 
carefully dried of any residue. These tubes were then weighed for a measurement of 
wet cell weight (WCW). They were then returned to the oven, removed and allowed 
to cool in a desiccator, and weighed periodically until a stable weight was reached, 
this being the dry cell weight (DCW g/L). A linear correlation between optical 
density at 600nm and dry cell weight was obtained as shown in Fig. 2.4. 
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Figure 2.4)Calibration curve showing Biomass concentration plotted against OD 
600nm  
 
This gave a reliable correlation between optical density (standard error bars plotted, 
n = 3 independent runs) and dry cell weight for E.coli cultures with the R2 value 
being 0.9792. The gradient, as shown on the graph was 0.408 (i.e. 1 unit OD600 is 
equal to 0.408 g/L in culture) This is useful as in practice it is much less time 
consuming to measure the OD of a sample and then calculate DCW, compared to 
measuring the cell weight directly. 
 
 
2.4.3. Protein analysis 
 
Two methods were used to determine either the level of total protein present in any 
sample or specifically the level of MTOX protein present. The level of total cellular 
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protein was determined with the Bradford assay (Bradford, 1976; Reed and 
Northcote, 1981). The principle of the assay is based on the absorbance shift from 
465 – 595 nm that occurs when Coomassie blue binds to proteins in acidic solution. 
 
 Protein levels in the sample were determined by comparison to a standard curve 
generated with serial dilutions of bovine γ globulin with the OD measured at 595nm. 
Cells were first lysed as described in section 2.2.7 by sonication. After sonication the 
cell lysates were centrifuged (17900 x g, 10min, 4oC) and the supernatant used for 
further analysis. 
 
Stacked SDS-PAGE (12% with 4% stacking, precast gel, BioRad) was used to 
visualise the protein make up of the samples after staining with Coomassie Brilliant 
Blue R-250 and washing in 5% (v/v) acetic acid. After sonication the supernatant 
contained soluble protein. Resuspending the pellet gave the insoluble protein 
fraction, whereas the sample after the initial sonication could be run as total protein. 
Protein gels were then stained with Coomassie before being photographed. 
 
For specific measurement of the MTOX protein the BCA assay was used (Thermo 
Scientific) following the supplier method to generate total cellular protein data. A 
SDS polyacrylamide gel was then run, stained with Coomassie brilliant blue and 
analysed using the Bio-Rad Gel Doc system. This compares the intensity and 
distance run of each band seen in the gel against a known concentration of control 
protein (Bovine serum albumin, BSA). From this comparison it is possible to 
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quantify the size and relative amount of protein present on the gel and therefore in 
the lysed cell sample. Results are shown in section 5.7. 
 
 
2.4.4. GFP fluorescence assay 
 
GFP was chosen as the model system for recombinant protein production partly due 
to its ease of measurement. 150µL of undiluted cell lysate was added to a 96 well 
plate and read with an excitation wavelength of 365nm ± 5nm and an emission 
wavelength of 510nm ± 5nm using a Tecan plate reader (Tecan, Switzerland) with 
Xfluor4safireII software. The signal was compared to a blank of wild type E.coli cell 
lysate. 
 
2.4.5. Peroxide assay 
 
The MTOX enzyme or N-methyl tryptophan oxidase is known to be able to convert 
N-methyl-L-tryptophan (sometimes known as L-Abrine) into L-tryptophan and 
peroxide. Therefore the assay for the detection and measurement of active MTOX 
protein was based on the production of this by-product shown in the following 
reaction scheme (Fig. 2.5) 
 
CH3NHCH(R)CO2-  + O2 + H20 ⇒ NH2CH(R)CO2- + CH2O + H202 
Figure 2.5) Reaction scheme for the oxidative demethylation of  N-methyl amino 
acids as catalysed by MTOX. 
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Samples of lysed cells were diluted to 1:100 and 1:1000, 50µL of this dilution being 
added to relevant wells in 96 well plates. 
 
The substrate, N-methyl-L-tryptophan was prepared by dissolving to a concentration 
of 10mM in a 50mM sodium phosphate buffer (pH 8.0) and placing in a sonicating 
water bath (37oC, 10min) to aid solubility. Once prepared, 0.5µl of substrate solution 
was added to each well and left at room temperature for 30min. After incubation 
with N-methyl-L-tryptophan the protocol for the Enzolyte™ ADHP Hydrogen 
Peroxide assay Kit (Anaspec, USA) was followed. This involved preparing a 
reaction mix of 50µL ADHP (10-Acetyl-3,7-dihydroxyphenoxazine) and 100µL 
Horseradish peroxidase, made up to 5mL with 0.01M PBS (pH 7.4) and then adding 
50µL to each well containing peroxide. The reaction proceeds as follows (see Fig. 
2.6) 
 
 
 
Figure 2.6) Reaction scheme describing the colorimetric reaction which is the basis 
of the MTOX enzyme assay 
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Readings were then taken after a further 30 min with the plate reader (Tecan, 
Switzerland) at 576nm for absorbance and emission at 590nm, excitation at 540nm 
for the fluorescence. 
 
The readings compared with a dilution series of peroxide gave results in terms of the 
amount of peroxide evolved and are therefore difficult to compare across differing 
strains/conditions. Quantification was undertaken however, based on Wagner’s 
method for the measurement and reporting of MTOX and MSOX activities, 
(Wagner, et al., 1999). In this method, units of activity are quoted; one unit of 
activity being defined as the formulation of 1µM peroxide/min at 25ºC following 
standard assay procedures.  In chapter 5 this measure is mainly used in conjunction 
with a measure of total amount of MTOX protein present. These two data sets can 
then be combined to produce a specific value of units of enzyme activity/mole 
MTOX protein present which is comparative across strains. It was realised however 
that the above assay was only measuring active enzyme, since MTOX requires the 
co-factor FAD to bind to confer activity and therefore exists in an apo- or inactive, 
or a holo-/active form. In answer to this problem the assay was modified using 
information about the ability of FAD to restore activity to apo enzyme produced 
(Hassan-Abdallah, et al, 2004). 
 
With the information that flooding the sample with FAD would convert ca. 90% of 
any apo enzyme to the holo form, the assay was altered to include a further 30min 
incubation with 1mM FAD into relevant wells of the 96 well plates after the addition 
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of substrate. An equivalent volume of RO water was included in each control well. 
After this incubation the peroxide assay as described above was carried out allowing 
the treated cells to give a reading of total enzyme produced and the control cells a 
reading of active enzyme originally produced. The results of these assays and 
comparative data before and after addition of FAD are presented in section 5.4. 
 
 
2.5. HPLC assays 
 
High performance liquid chromatography was used for two different separations 
throughout the work. Initially a column and a UV detector were used for the 
separation of organic acids and the determination of glucose and acetate levels at 
various points throughout the fermentation. Further into the work a second rig was 
used with fluorimetric detector to measure levels of FAD, FMN and riboflavin in 
clarified culture lysates. 
 
2.5.1. HPLC analysis for Glucose and Acetate 
 
A Dionex HPLC rig was used with an Aminex HPX – 87P ion exclusion column 
(300 x 7.8mm, 9µm pore; specific for organic acid and alcohol separations (BioRad, 
UK)) with a mobile phase of 5mM H2SO4 running at 0.8mL/min. Fermentation 
samples were centrifuged (17,900 x g, 10min) and the supernatant sterile filtered 
through a disposable 2µm syringe filter. Samples were also prepared with serial 
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dilutions of a known concentration of glucose and acetate. The standard curves 
generated are shown in figure 2.7. 
 
 
Figure 2.7) Standard curve of Glucose and Acetate using HPLC 
 
Detection was with refractive index (RI) (as shown above) or UV 210nm with the 
acetate peak having a retention time of about 9 minutes and the glucose, 14 min. 
 
 
2.5.2. HPLC analysis for FAD, FMN and Riboflavin 
 
As much of the work in chapter 5 aimed to increase levels of cellular FAD it was 
important to have a robust method for the separation and measurement of FAD, 
FMN and riboflavin. Samples were prepared after perchloric acid quenching 
(described in section 2.2.6) by lysing the cells, centrifuging to remove cell debris 
and then sterile filtration to avoid clogging the HPLC column. The method 
employed was an adaptation of Barile’s paper of 1997, (Barile, et al. 1997) but also 
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drew on other work by the same author and others, (Barile, et al. 1993, King,  et al 
1962). 
 
Separation was achieved using a Chronusil-S ODS-2, 5µm x 25mm x 0.46mm 
HPLC column connected to a Dionex P580 pump and AS350 autosampler which 
was kept chilled and protected from light at all times. Detection was possible using a 
Jasco fluorimetric detector (using excitation and emmision wavelengths at 450nm 
and 520 nm respectively). All hardware was controlled using Chromelion software 
(Dionex Corp, Sunnyvale, CA) except the detector wavelengths and gain, which had 
to be set manually. 
 
A gradient was used for the mobile phase consisting of two solutions, A and B. Both 
were a 20mM potassium phosphate base with either 25% (v/v) (A) or 50% (v/v) (B) 
methanol added. All standards and samples (40µL) were injected and eluted at room 
temperature for 6 min 40 sec with solvent A followed by 13 min 20 sec for solvent B 
at a flow rate of 0.75 mL/min. 
 
Figure 2.8) Standard curves generated by HPLC of Riboflavin and FAD 
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Standards curves were generated for riboflavin and FAD and are shown in Figure 
2.8. Solutions of FMN standards however did not generate one single peak, with 
peaks forming at retention times known to correspond to FAD and riboflavin. It was 
therefore assumed FMN was too unstable in solution, even storing all sample 
solutions refrigerated and in the dark , to not partially break down into the two other 
compounds. 
 
 
2.6. Statistics and calculations 
 
A number of statistical manipulations were necessary to analyse and compare data 
sets generated in the course of the study, these are explained below. 
 
2.6.1. Coefficient of variance 
 
Coefficient of variance can be described as the degree to which a set of data points 
varies. The larger the final value the more variation there is in the data set compared. 
Although not a measure of statistical significance, % CV can be used as a useful tool 
for the initial comparison of a number of data sets. It is calculated using the equation 
below. 
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Equation 2.1) Formula for the calculation of the dimensionless number, coefficient 
of variance 
 
 
As shown Cv is the ratio of the standard deviation (σ) and the population mean (µ). 
Multiplying the result by 100 gives percentage Cv. 
 
2.6.2. Student’s T-test 
 
The Student’s T-test is commonly used to test the null hypothesis that the means of 
two normally distributed populations are equal generally assuming the variance of 
both populations is also equal. As shown in equation 2.2 this need not always be the 
case as the heterscedastic T-test, (often referred to as Welsh’s T-test) can be used 
where variances are unequal.  
 
Common to all T – tests is the fact that the result achieved from the calculation 
needs to be compared to a table of critical values which will vary depending on the 
confidence level (generally taken as 95%) and the degrees of freedom. If the 
calculated value from the T – test is lower than the critical value the null hypothesis 
is upheld and no significance is seen between the two sample means compared. 
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Equation 2.2) Formula used to calculate the Student’s T-test statistic for two sample 
populations assuming equal variance (Homoscedastic T-test)  
 
 
X, Y = population means 
Sp = pooled standard deviation 
n = population size for each data set 
 
For this test, the calculation of degrees of freedom is simple being  n1 + n2 – 2. 
 
 
 
Equation 2.3) Formula used to calculate the Student’s T-test statistic for two sample 
populations assuming unequal variance (Heteroscedastic T-test) 
 
S2x = standard deviation of X 
S2y = standard deviation of Y 
 
The calculation of degrees of freedom for this statistic is much more complex than 
for the homoscedastic test and is shown below. 
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Equation 2.4) Formula used to calculate the degrees of freedom used for the 
heteroscedastic T-test as shown in equation 2.2. 
 
S = standard deviation 
 
n = population size 
 
 
 
2.7. Modelling   
 
Much of the work done in Chapter 6 is based on a metabolic reconstruction of the 
MG1655 K-12 strain of E.coli. The reaction network used was developed by 
Bernard Palsson (Edwards, and Palsson, 2000) and is a constraint based model of 
E.coli metabolism. This model was developed using published information such as 
the annotated gene map and other physiological and biochemical information, 
(Joyce, et al, 2006 and Reed, et al, 2006). It therefore consisted of a reaction network 
for the maintainence of the E.coli cell and the requirements of carbon sequestering 
during growth. Crucially for the work planned it also included the riboflavin 
pathway described in Chapter 1. 
 
The model was constrained by the known ATP requirement for cell maintenance of 
7.6mM/g(DCW)/h and an initial glucose uptake rate of 2mM/g(DCW)/h. Also a 
stociometric equation was generated based on the amino acid sequence of the solA 
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gene product, (Koyama, and Ohmori, 1996). This, in addition to the riboflavin 
pathway would allow the comparison of MTOX production with FAD levels and 
also demonstrate how demands through these two pathways would effect the 
maximum specific growth rate. 
 
Mutations could be included and as such the model was altered slightly to 
accommodate for the mutant strains background of BW25113 (see table 2.1).  
 
Once the initial set up was achieved questions were asked of the model in terms of 
Biomass production, MTOX production and also FAD production. Plots were then 
generated in an attempt to determine the relationships between these three carbon 
sinks.  
 
As detailed in Chapter 6 initially a maximum specific growth rate was calculated by 
setting all carbon flux into biomass accumulation. This allowed an estimation of the 
maximum theoretical growth rate of 0.5 h-1 as shown in Figure 6.1. Then as growth 
rate was incrementally decreased and all available flux redirected to MTOX protein 
production an estimation of maximum MTOX molar flux was determined alongside 
a plot of MTOX production against growth rate. 
 
This approach was then also used to compare flux to the MTOX protein and FAD 
with two differing glucose uptake rates and additionally no growth, (shown in Figure 
6.2). Finally a comparison of the three variables was performed which gave 
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information on the production of the MTOX protein, the cofactor needed for its 
activation and also the potential growth rate achievable at certain levels of protein 
production. This then gave a window of operation which could be compared with 
experimental values generated in the laboratory investigations. A discussion of 
where the predictions of the model deviated from the data generated in the 
laboratory is included in Chapter 6. 
 
 
Chapter 3:   Method Development 
 58 
3. Method Development 
 
 
 
3. Method Development ......................................................................................58 
3.1. Introduction..............................................................................................59 
3.2. Bacterial lysis using sonication .................................................................60 
3.3. Flavin Stability .........................................................................................61 
3.4. FAD spiking experiments .........................................................................64 
3.5. Summary ..................................................................................................66 
 
 
Chapter 3:   Method Development 
 59 
3.1. Introduction 
 
This chapter describes experiments designed to develop methods enabling further work to 
be carried out on the host strains and the proteins that were being produced.  
 
It initially details work done to investigate the optimal conditions for bacterial lysis, 
necessary for the further analysis of intra-cellular proteins, co-factors and enzymes. The 
optimum conditions determined in these experiments were used for the lysis of all 
bacterial samples throughout the work. 
 
It goes on to detail and explain the development of an HPLC method for the separation 
and measurement of FAD, from its related compounds, FMN and riboflavin. As the level 
of active MTOX enzyme was directly related to the level of FAD present accurate 
measurement of the concentrations of this co-factor was vital to the study. 
 
Methods and results described in this chapter directly relate to the work detailed in the 
following chapters. 
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3.2. Bacterial lysis using sonication 
 
Bacterial lysis was carried out via sonication (Soniprep150, Sanyo, Japan) in lysis buffer 
(10mM Na2PO4, 1mM EDTA, 10mM MgCl2) (see materials and method section 2.2.7) 
  
The initial experiment was undertaken to determine the optimum conditions for the lysis 
to take place. Eight conditions were looked at with varying sonication frequencies and 
durations. After lysis an estimation of total cellular protein concentration released was 
undertaken (see section 2.4.3) and also a measure of enzyme activity, calculated using the 
method for MTOX enzyme activity described in section 2.4.5. The data is presented 
below. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1) Comparison of 8 different lysis conditions with the resulting total protein 
yield and enzyme activity (Conditions were: 1 – 6kHz : 5 sec, 2 – 6kHz : 10sec, 3 – 8kHz 
: 5 sec, 4 – 8kHz : 10 sec, 5 – 10 kHz : 5 sec, 6 – 10kHz : 10 sec, 7 – 4kHz : 5 sec, 8 – 
4kHz : 10 sec) All consisting of 5 cycles (see materials and method section 2.2.7 for 
details) 
 
 
It was shown that condition 6 (10 kHz for 10 s) produced the largest total protein 
concentration, suggesting the most efficient cell lysis. However for this condition MTOX 
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activity was low potentially due to enzyme denaturation caused by extreme lysis 
conditions. Instead it was decided to use condition 4 (8 kHz for 10 s) for all further cell 
breakage because it gave a good compromise of efficient cell breakage coupled with 
minimal damage to the enzyme product.  
 
With levels of cellular breakage and total protein yields being adequate for the work 
planned this methodology was thought sufficient. Chemical lysis agents were 
investigated such as the Bugbuster® reagent (Novagen) and others. Chemical agents are 
known to be efficient and reliable for cell lysis but as no sample clean up of the cell 
suspension was planned with the exception of centrifugation it was thought that 
compounds used in the lytic process may remain and could have an effect on the assays 
carried out post-lysis. 
 
 
 
3.3. Flavin Stability  
 
Initial work was needed to adapt the assay described in Barile’s paper (1997) and to 
generate data from standard solutions of FMN, FAD and Riboflavin and also ensure 
complex mixtures could be separated using the same technique. 
 
As described in the Materials and Methods (section 2.4.5) a method was developed based 
on work done by Barile et al, (1997) but also drew on earlier work from the same author 
and others (Barile et al., 1993, King et al., 1962). It relied on HPLC separation of FAD, 
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FMN and riboflavin and fluorimetric detection of these flavin metabolites from clarified 
lysates generated in shake flask fermentations of the E. coli strains used in this study. It 
was known that riboflavin and its derivatives fluoresced strongly and that a simple 
measurement at 450 nm could be undertaken, however this would have given no 
indication of how the flavin component of the cell is partitioned at any one time into 
FAD, FMN and riboflavin. As this information was crucial to the activation of MTOX, as 
the enzyme requires FAD as a co-factor conferring activity, HPLC had to be employed. 
 
Initially standard solutions were run which highlighted the importance of storage 
conditions for both the samples in preparation, and once awaiting analysis. It was 
understood that FAD would be utilised by the cells, especially expressing a protein 
requiring the compound to confer activity, which therefore required the use of perchloric 
acid quenching in the eventual experimental fermentation runs (see section 2.2.6). 
However the degree to which FAD would degrade naturally throughout normal 
laboratory preparation was highlighted after the first standard run. 
 
As shown in Figure 3.2 a sample of 20µm FAD when subjected to normal laboratory 
preparation but 24 hours delay (caused by equipment failure) showed significant 
degradation of FAD (amounting to 93% loss) to FMN (90%) and riboflavin (3%), the 
three main peaks shown matching retention times quoted in literature. Barile et al. (1997) 
stated retention times for all three compounds as “about 4, 5 and 8 minutes for FAD, 
FMN and riboflavin respectively” with a flow rate of 1mL/min. Correcting for a lower 
flow rate of 0.75mL/min these times equate to approximately 5.3, 6.7, and 10.7 minutes 
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giving a good correlation to figure 3.2. Although unplanned this gave a useful insight into 
the importance of speed of analysis and storage conditions when dealing with further 
samples. It is true that some degradation is inevitable however after this finding all 
samples were treated equally and analysed as soon after sampling took place as possible. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.2) Chromatogram of 20µm FAD standard solution after HPLC separation and 
fluorescent detection (Peaks relate to FAD[5.68 min], FMN [6.89 min], and Riboflavin 
[10.51 min]) 
 
 
Shake flasks were then run in the same way as described previously with samples being 
taken at various time points throughout growth. As described in section 2.2.6 samples 
were immediately quenched with a 1.6M solution of perchloric acid, neutralised and then 
stored at 4ºC in the dark until analysis could be performed.  
 
0.0 2.0 4.0 6.0 8.0 10.0 12.0 15.0
-200
0
200
400
600
800
1,000
1,200 FADH2 analysis #18 [modified by Paul] Jasco
mV
min
1 - 1.9542 - 2.6923 - 2. 074 - 3.4995 - 3.7536 - 4.088
7 - 5.675
8 - 6.893
9 - 10.506
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3.4. FAD spiking experiments  
 
 
As an important control, spiking experiments were carried out to determine the 
percentage recovery of FAD achievable using the modified HPLC method. As detailed in 
section 2.4.5, 10µM FAD was added to each plasmid free strain cell suspension prior to 
lysis. 10µM FAD was also added to fresh media and subjected to the same lytic 
procedure. Finally the same amount of FAD was spiked into fresh media and then sterile 
filtered before analysis via HPLC. The results are shown below. 
 
Table 3.1) Percentage recovery of 10µM FAD added to samples of E.coli cell suspension 
prior to lysis. 
 
Strain/Matrix FAD recovered [µM] % recovery 
MG1655 6.0 60.9 
TG1 6.5 66.2 
appA 6.3 64.2 
cobB 6.6 67.5 
cobT 6.0 60.5 
 Media (lysed) 8.0 81.0 
Media (unlysed) 9.9 98.4 
 
It was shown that regardless of the E.coli strain used approximately 60-68% of the FAD 
added (6.0µM – 6.6µM) could be recovered after sonication and analysis via HPLC. 
 
It was concerning that approximately 35% of the FAD seemed to be lost but the 
consistency over the 6 strains suggests that measurements of cellular FAD previously 
made throughout and during the course of the study would be accurate for all strains used 
with a potential underestimate of ca. 35% for each. It was suggested that part of the loss 
could be explained by the degradation of FAD to FMN and riboflavin (discussed further 
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in section 5.8). To investigate this, fresh media with FAD added was subjected to 
sonication prior to analysis. A better result was obtained than with the cellular extracts 
but still 20% less than the FAD spiked into fresh media and analysed without lysis was 
recovered (see table 3.1). This suggested that part of the loss was directly related to the 
degradation of FAD during the sample preparation steps. On re-analysis of the 
chromatograms increased peaks relating to FMN and riboflavin were seen to account for 
almost all of this 20% loss. This suggests that degradation was caused by sonication but 
only accounts for half the loss seen in the cell extracts. It is known that there are a 
number of intracellular proteins that will utilise free FAD, proteins such as fumarate 
reductase and succinate dehydrogenase both found in E.coli have flavoprotein subunits 
which may be utilising the additional FAD (Brandsch, & Bichler, 1989). There may also 
be a small amount lost to non-specific binding. Since all samples were from plasmid free 
strains MTOX will not be present in large amounts to account for any significant loss. A 
certain amount of work has been done studying FAD stability in differing temperatures in 
blood plasma, these broadly agree with the trends suggested here (Akimoto, et al. 2006). 
 
They showed a much higher rate of FAD hydrolysis to FMN at raised temperatures, 
(37˚C) than seen at low temperature, (4˚C). With FAD concentrations dropping to almost 
zero after 30 minutes at elevated temperature. This underlined the importance of 
refrigerating the samples whether during storage or during HPLC analysis where the auto 
sampler was also cooled to between 2 and 8˚C.  
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Akimoto also showed that predominantly all FAD is hydrolysed to FMN and the 
subsequent conversion to riboflavin is relatively slow (even at higher temperatures). This 
agrees with the findings presented in Figure 3.2 where the peak of FMN is significantly 
larger than the one attributable to riboflavin. 
 
 
 
3.5. Summary 
The experiments described here were necessary for the analysis of cultures expressing 
either GFP or MTOX proteins. These investigations were vital to develop and optimise 
two techniques that would be used throughout the course of the work. 
 
It was shown that with the sonication method of cell lysis there was a trade off between 
maximum cell breakage and intracellular protein integrity. This resulted in a compromise 
to be used where high degree of lysis was achieved without affecting the integrity of the 
desired protein product severely. 
 
Secondly the transfer and optimisation of an HPLC method for separation of FAD, FMN 
and riboflavin was shown. This was crucial to the further understanding and 
measurement of intracellular levels of the three compounds, directly relevant to riboflavin 
metabolism and the activity of MTOX. This work also gave an insight into FAD stability 
and altered the way samples were collected, stored and the timeframe in which they 
needed to be analysed. 
 
Chapter 3:   Method Development 
 67 
Finally a spiking experiment was performed to determine what proportion of FAD could 
be recovered prior to HPLC analysis. A loss was seen throughout the sample 
manipulation but this was consistent across the range of E.coli strains tested. This loss 
was attributed partly to the degradation of FAD caused by the exposure to light and 
elevated temperatures during the sonication process, and partly to FAD binding to 
intracellular flavoproteins inherent in the E.coli cell. This level of loss has been 
accounted for throughout the following chapters, particularly were FAD levels estimated 
in silico are compared to experimentally derived values. 
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4.1. Introduction 
 
The rational behind the work in this chapter was to provide data about the initial 
strain of E.coli used in the investigation and to develop methods that would be used 
throughout the course of the work. Experiments determining the growth 
characteristics of E.coli MG1655 (Blattner et. al, 1997) wild type strain and the level 
of native protein present were carried out to establish a baseline for bacterial growth 
before the introduction of a foreign protein expressing plasmid.  
 
As mentioned earlier Green Fluorescent Protein (GFP) was chosen to act as a model 
protein product due to its ease of detection and plasmid availability. The plasmid 
construct puvGFP was therefore introduced into MG1655 and differences in growth 
characteristics, total cellular protein production, carbon utilisation and GFP 
production were studied. 
 
Shake flask experiments made up the bulk of the fermentations due to the ability of 
using these for a higher number of duplicate runs than would be possible with larger 
scale stirred tank reactors This fitted with the aims of developing a higher 
throughput method for screening and selection of mutant strains, differing media, 
and differing plasmid constructs that were foreseen at this early stage of the work. 
However data such as dissolved oxygen tension (DOT), off gas analysis or even 
automatic pH control is not available when using shake flasks. Therefore a number 
of 5L scale stirred tank cultivations were undertaken to allow comparison of the two 
systems.  
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4.2. Growth Characteristics and Plasmid effects on cellular growth in SFs 
 
Initial experiments were carried out using the wild type E.coli strain MG1655 on M9 
minimal medium (see Table 2.2 for constituents). As shown in Table 4.1, growth on 
this medium was slow and achieved low final cellular concentrations. Growth at this 
level was thought not ideal for the planned work. It has been discussed earlier that 
mutations made in the E.coli genome may only have a small effect on cellular 
growth therefore a medium that provided faster, more reliable growth to a higher 
final OD was sought.  
 
The obvious choice for an alternative would have been complex media. This was 
initially rejected on the grounds that a detailed composition of such media was not 
available. Accurate amounts of carbon input were required for the planned 
modelling work (see Chapters 1 & 6) and therefore ruled out the use of undefined, 
complex media. Therefore M6 minimal medium was investigated as an alternative. 
It was shown that cultures on M9 grew to a significantly lower final OD than those 
on M6 (T-test result: 4.97 > 2.132: 95% df=4).  The rate of growth was less 
convenient to analyse having non-equivalent variance. To overcome this problem 
ANOVA was employed to determine whether M9 values came from the same 
population as the M6 data. The test returned a critical F value of 5.99 (>5.208, F crit 
95%, 6 degrees of freedom), and was therefore scored as significant. 
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Table 4.1) Maximum specific growth rates and confidence intervals for 4 differing 
growth investigations of E.coli MG1655 grown in shake flask cultures. 
 
Strain and Media µmax (h-1)* Mean OD 
(600nm) 
Mean CV 
(95%) +/- 
E.coli MG1655 WT, M9  
E.coli MG1655 WT, M6 
E.coli MG1655 puvGFP, M6 
uninduced 
E.coli MG1655 puvGFP, M6 
induced 
0.42 ± 0.11 
0.62 ± 0.06 
0.56 ± 0.08 
 
0.55 ± 0.06 
 
1.168 
2.660 
2.313 
 
2.247 
0.096 
0.062 
0.079 
 
0.060 
* = example calculation included in appendix 3 
At this stage a plasmid construct puvGFP (see materials and methods section 2.3) 
was introduced into the host strain. Growth of this plasmid carrying strain, with and 
without induction (1mM IPTG at an OD ~ 1.0), and the plasmid free strain, was 
compared by determining biomass concentration and growth rate.  
 
 
Figure 4.1) Growth profiles for three independent runs (n=3) of MG1655 WT and 
plasmid carrying strain on M6 media (induction with 1mM IPTG at T = 3h) grown 
in SFs.  
 
 
It was noted that the variability of each shake flask run was generally reduced as is 
shown with a comparison of percentage CV in Table 4.1 above.  
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From the above data sets a baseline was produced for the growth of the non-plasmid 
carrying strain and the plasmid containing strain grown in M6 minimal medium. It 
was noticed that bacterial growth was slightly reduced in the plasmid carrying strain 
compared to the wild type strain, but no significant difference was seen when GFP 
protein production was induced with 1mM IPTG at a culture OD of approximately 1. 
 
The initial shake flask fermentations provided some basic data on the growth 
characteristics of E. coli MG1655 wild type and plasmid containing strain. The 
growth curves in Fig. 4.1 show no significant difference in shape between the 
different strains tested. Generally, as would be expected, a lag phase is seen 
followed by a period of exponential growth which lasts until approximately 8 – 9 
hours into the experiment. At the end of the fermentation a stationary phase is 
observed where the rate of cell division equals that of cell death and no increase in 
the broth turbidity is seen. 
 
 
4.3. Analysis of carbon consumption and acetate formation of SF cultures 
 
In an attempt to further constrain cellular growth in order to understand and observe 
potentially small changes originating from single gene deletions to be evaluated (see 
Chapter 5) the cultures were designed to be carbon limiting. In order to measure the 
amount of carbon source available at various points throughout the growth 
experiments, and to monitor the accumulation of acetate, a known carbon sink often 
produced when a cell is undergoing metabolic stress (Kirkpatrick et al., 2001); 
glucose and acetate levels were measured as described in Chapter 2, section. 2.5 
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 Results in Figure 4.2 show that glucose levels dropped during the course of the 
shake flask fermentations due to carbon consumption by the organism. After 7 hours 
this carbon source has been exhausted which corresponds well with the beginning of 
stationary phase.  Acetate levels rose over time reaching a plateau at 6 hours, again 
roughly corresponding with the end of exponential growth. 
 
 
* Note all error bars are variation due to triplicate reading of a single sample 
Figure 4.2) Growth profile of three independent runs (n=3) of MG1655 WT showing 
OD, glucose consumption and acetate production throughout a 10 hour shake flask 
fermentation in M6 medium.  
 
Using sets of data for each set of shake flask samples and the calibration of OD to 
dry cell weight, yields of biomass on glucose and also acetate on biomass were 
calculated. (see Table 4.2). 
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Table 4.2) Summary of parameters characterising growth of MG1655 WT and MG 
1655 puvGFP grown in shake flasks. 
 
Strain and Media  µmax (h-1) Xmax (g/l) Yx/glu (g/g)* Yac/x (g/g)* 
E.coli MG1655 WT, M6 0.62 ± 0.06 1.72 0.43 1.17 
E.coli MG1655 puvGFP, M6 uninduced 0.56 ± 0.08 1.56 0.39 1.28 
E.coli MG1655 puvGFP, M6 induced 0.55 ± 0.06 1.50 0.38 1.30 
* = example calculations included in appendix 3 
 
 
Values stated in table 4.2, seemed to suggest a small increase in acetate production 
between the plasmid free strain and that with the plasmid, also another increase 
between the uninduced and induced cultures however none of these were shown to 
be statistically significant, (values for the T-statistic were calculated between WT 
and puvGFP induced = 0.53 < 2.132 [P=0.95: d.f.= 4], values between the uninduced 
and induced strains = 0.09 < 2.132) It has been suggested that acetate production 
increases with rising metabolic stress (Hahm, et al., 1994) as acetate metabolism can 
be used as an additional source of energy and important metabolic precursors 
(Chang, et al., 1999) this result seemed to support that hypothesis. 
  
 
 
4.4. Total Protein analysis of SF cultures 
 
In order to quantify the amount of GFP produced, total protein analysis was carried 
out in the different strains used. This was performed on six E.coli culture samples of 
each type to ascertain the total amount of intracellular protein present in the wild 
type, plasmid uninduced and plasmid induced strains growing on M6 media.  
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The data is presented in the table below. 
 
Table 4.3) Total protein in samples of E.coli MG1655 WT and MG1655 puvGFP 
uninduced and induced with IPTG (OD ~ 1.0) T=0 refers to the sample taken at the 
start of the fermentation, T=3 is taken immediately after induction with 1mM IPTG 
T=4 being one hour after this. The final timepoint T = 7 equates to the stationary 
phase of the culture 
 
 Total protein conc [mg/ml] 
Strain 0h 3h 4h 7h 
WT 0.83 ± 0.06 1.03 ± 0.41 1.12 ± 0.18 1.91 ± 0.09 
Uninduced 0.64 ± 0.09 1.23 ± 0.15 1.62 ± 0.22 2.30 ± 0.24 
Induced 0.61 ± 0.12 1.01 ± 0.10 1.75 ± 0.25 2.41 ± 0.13 
 
 
Due to the nature of the low volume shake flask cultures it was not possible to 
analyse every time point of the fermentations. Since 1mL was the minimum sample 
size that was found to be adequately lysed via sonication (see Materials and Methods 
section 2.2.8), four time points were chosen and analysed.  
 
When stationary phase was reached a small increase was seen in total intracellular 
protein between the plasmid free and the plasmid carrying strain, (Table 4.3). 
Performing a Student T-test on these two data sets gave a result of 8.80, above the 
tabulated value of 2.132 (df=4) and is therefore a significant difference at the 95% 
confidence level. 
 
A less clear difference was seen between the uninduced and induced plasmid 
carrying strains. It was assumed that, with the production of green fluorescent 
protein the amount of total protein measured from the induced sample would be 
considerably higher than for the uninduced. This was not the case. On performing 
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the Student T-test on these sets of data a result of 4.23 is returned (n=3) and as such 
showed this to be a non-significant difference, (again P=0.95). 
 
 
4.5. Verification of GFP production in SF cultures by SDS-PAGE  
 
As verification that GFP was indeed being produced after induction SDS-PAGE was 
carried out and run with total protein and soluble protein for each of the conditions. 
 
 
 
Figure 4.3) SDS – PAGE of MG1655 plasmid free (lane 1), and MG1655 puvGFP 
showing the 27kD protein. GFP Samples were taken from 3 hours post induction; 
the lanes were loaded as follows: 
 
Lane 1: MG1655 plasmid free clarified cell lysate 
Lane 2: MG1655 puvGFP total cell lysate sample 
Lanes 3&10: Molecular weight ladder (Daltons) 
Lanes 4 – 6: MG1655 puvGFP clarified cell lysate samples (uninduced) 
Lanes 7 – 9: MG1655 puvGFP clarified cell lysate samples (induced) 
 
 
At this stage, gels were used to verify the presence of the protein rather than to 
quantify the amount present so no further analysis was completed. A band was seen 
   1          2         3         4           5          6          7          8           9       10 
204065 
115438 
94919 
54343 
37343 
29104 
20170 
GFP 
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at approximately 27kD daltons in all the sample lanes (numbers 2, 4 – 9), which was 
not seen in the plasmid free control (lane 1) suggesting the presence of green 
fluorescent protein, which has a molecular weight of 27 kD. There is also a band 
seen (although less clear than at 27kD) at approximately 54kD. This is thought to be 
caused by the propensity of UV optimised GFP to form dimers, a phenomenon not 
seen in other variants according to the manufacturer (Source: BD catalogue). 
However, rather unexpectedly a clear band can be visualised at 27kD for samples 
induced with IPTG and also those not induced. This implies a lack of control over 
expression of the construct used, and has been investigated further (see Section 
4.10). 
 
 
4.6. Determination of GFP expression in SF cultures by Fluorescence assay 
 
The assay (described in Chapter 2, section 2.4.4) was designed to be a fast and 
effective way of comparing different E.coli strains expressing GFP. Compared to the 
Bradford assay for total protein or SDS-PAGE, this fluorescence assay could be 
performed simply and quickly for a range of cell lysates in a 96 well plate. Data was 
collected for non-lysed samples and, although the trends were similar to that 
obtained from lysed cells, the signal was much reduced. Using non-lysed cells would 
increase the throughput of the assay but the potential loss of precision was thought to 
be too great especially as very small differences in protein expression were expected 
with some of the deletion mutants to be used. Therefore only data from lysed and 
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clarified samples are shown in figure 4.4. All samples were obtained from 3 hours 
post induction with IPTG.  
 
 
 
Figure 4.4) Fluorescent signals for three conditions of MG1655 puvGFP(un-
/induced) and MG1655 (plasmid free) grown in SFs on M6 medium. Samples were 
taken immediately before and 3 h after time of induction.  
 
Expanding upon experiments done to assess total protein production and presence of 
GFP, Figure 4.4 shows the difference seen in fluorescence signal at two points in the 
growth of E.coli strains. RFU was used as stated units as no reference standard for 
GFP was available and comparative data, all that was deemed valuable.  
 
A low signal is seen from the plasmid free strain indicating that wild type MG1655 
has a small amount of inherent fluorescence at the wavelengths used but this was 
less than 10 times the response seen in the other two samples, and was therefore not 
thought significant. No change is seen after the addition of IPTG and the one tailed 
T-test (see Materials and Methods, section 2.6) returns a value of 0.96. This is well 
below the threshold value of 2.132 (P=0.95: n=4) thus the differences between the 
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pre – and post – induction plasmid free strain  samples are not significant and this 
acts as a valid control. 
 
As the variance of the uninduced and induced data sets of the plasmid carrying 
strains was not equal, the heteroscedastic t-test was employed, (see Chapter 2, 
section 2.6). The obvious differences seen were confirmed with a value of 21.63 for 
the uninduced and 12.81 for the induced samples. Both of these values were above 
the critical value of 2.353 (d.f.=3: 95%) and therefore showed significant differences 
in the means of each sample group. 
 
There were some interesting findings when the same time points for uninduced and 
induced samples of plasmid containing strains, were analysed. As expected (since no 
induction had taken place) the differences between uninduced and induced pre-
induction were not significant  (T=2.51 < 5.841 [P=0.95: n=3]). Again due to 
differing variances between the plasmid free and the plasmid carrying the 
heteroscedastic test was used and returned a result of 31.26, again above the critical 
value of 2.353 (d.f.=3 : 95%) showing a significant difference between the two. 
What was more unexpected is that no significant difference was found between the 
uninduced and induced samples, 3 hours post induction, (T=12.36 > 5.841 [P=0.95: 
n=3]). GFP seemed to be expressed regardless of induction with IPTG in these shake 
flask cultures. There was an assumed significant difference between the plasmid free 
strain and both the puvGFP strains even before induction, and no significant 
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difference between the induced and uninduced strains 3 hours after induction had 
taken place. 
 
As stated earlier experiments were mainly undertaken in shake flask culture however 
a limited number of stirred tank reactors were utilised to give a comparison between 
small and medium scale culture. The data from these experiments follows. 
 
 
4.7. Characterisation of growth parameters in 7L stirred tank reactors 
 
 
Figure 4.5) Comparative growth curves for plasmid free MG1655 and MG1655 
puvGFP uninduced and induced grown in M6 medium in 7L stirred tank reactors, 
induction with 1mM IPTG occurs at T=2 h. 
 
 
Compared to shake flask cultures a higher final OD, faster growth rate and a shorter 
lag phase was seen in bioreactor cultures. On the other hand, similar to results 
obtained in SFs there was a difference between the plasmid free and the plasmid 
carrying strains. Unlike earlier experiments a significant difference in growth rates is 
seen between the plasmid induced and uninduced strains as well as the plasmid free 
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control. However due to the time involved running these medium scale 
fermentations the sample population for each was too low (n=2) to quote statistical 
values. 
 
As with earlier shake flask cultures the consumption of carbon source and the 
production of acetate were determined. The data is presented in Table 4.4. 
 
 
Table 4.4) Summary of parameters characterising growth of MG1655 WT and 
puvGFP on M6 medium in 7L stirred tank reactors (STR) 
 
Strain and Medium  
 
µmax (h-1) Xmax 
(g/l) 
Yx/glu 
(g/g) 
Yac/x 
(g/g) 
E.coli MG1655 WT, M6 (STR) 0.71 ± 0.090 2.53 0.63 0.88 
E.coli MG1655 puvGFP, M6 uninduced (STR) 0.63 ± 0.065 2.40 0.60 1.00 
E.coli MG1655 puvGFP, M6 induced (STR) 0.59 ± 0.035 2.24 0.56 0.95 
 
 
The better control over culture temperature, pH and levels of dissolved oxygen 
(DOT) in STRs commonly produces faster growing batches which achieve higher 
final ODs and therefore higher yields of biomass per unit carbon (Michel Jr. et al., 
1990). Furthermore, the yields of acetate were reduced compared to the shake flask 
cultures (see Table 4.2), potentially a sign of lower metabolic stress caused by 
growth conditions being closer to optimal (e.g. Kirkpatrick et al., 2001). The trend 
that was seen in shake flasks where acetate production was higher in the plasmid 
carrying strain relative to the plasmid free strain is borne out although no significant 
difference is seen between the two states of plasmid carrying cultures. In addition, a 
greater difference in Yx/glu between wt and plasmid containing strain was obtained. 
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In contrast to SF cultures there seemed to be clearer difference between un- and 
induced state that may suggest an additional metabolic burden and better control of 
GFP expression.  
 
 
4.8. Total protein analysis of bioreactor samples 
 
As with experiments run under shake flask conditions total protein analysis was 
carried out to determine the amount of total intracellular protein present in each 
sample. Table 4.5 data shows total protein data obtained after 3 hours of cultivation.  
Table 4.5) Total cellular protein for plasmid free and two plasmid containing 
cultures in 7L stirred tank fermentations 1 hour post induction 
 
Strain  Total Protein (mg/ml) 
Plasmid Free 2.24 ±0.11 
Uninduced 2.46 ±0.12 
Induced 2.54 ±0.13 
 
The trend is very similar to that seen earlier with the small-scale cultures. Analysis 
using the T-test is possible and comparing the protein yield of the plasmid free with 
that of the uninduced a value of 2.27 is obtained, this being above the threshold 
value of 1.943 (P=0.95) a significant difference was seen. Conversely, comparing 
the uninduced and induced data sets a value of 0.235 is calculated proving that there 
is no significant difference in the two means. 
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4.9. Determination of GFP expression in bioreactor cultures using 
fluorescence assay  
 
In a similar way to shake flask, samples were analysed in triplicate for fluorescence 
and the data generated is shown below.  
 
 
 
Figure 4.6) Comparative plot of normalised fluorescence for MG1655 puvGFP 7L 
stirred tank cultures in M6 medium (one induced at t=2h with IPTG, the other 
uninduced) 
 
 
 
Fig. 4.9.1 shows a marked difference in fluorescence profiles over the course of the 
experiment between the induced and uninduced cultures. The possible reasons for 
these differences are discussed in section 4.11, however it was thought that the 
difference in growth rate seen may have been causing this effect. In fact, the most 
marked difference between the growth of MG1655 puvGFP in shake flasks and 
stirred tank reactors was that of maximum specific growth rate and, to some extent 
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linked to this, final cell density. It was therefore decided that comparative runs of 
MG1655 puvGFP would be undertaken using Luria Bertani broth (LB), in an 
attempt to increase specific growth rate to a level approximating that seen in stirred 
tank reactors. 
 
4.10. Shake flask experiments in LB medium 
 
These experiments were conducted in exactly the same way as those previously 
replacing M6 medium with LB. A comparison was then made between the 
fluorescence profile of the shake flask culture and that of the bioreactor cultures 
grown in M6 medium (see Fig. 4.7). In addition the specific growth rates and other 
parameters of the cultures grown under different conditions were compared (see 
Table 4.6),  
 
 
Figure 4.7) Comparison of normalised GFP fluorescence in cultures of MG1655 
puvGFP grown in SFs and STRs. 
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The profile of fluorescence (implying the production of GFP) was seen to follow 
similar profiles for the shake flask experiments using LB medium compared with the 
data collected from the stirred tank experiments using a defined medium. All 
cultures show a slow increase in fluorescence from time 0 (where the seed culture 
was added) until 1 hour. At time point 1 IPTG was added at a concentration of 1mM 
and the two groups were seen to diverge. The uninduced cultures showed a slowing 
of increase of fluorescence, which reached a plateau 2 hours into the fermentation. 
The induced cultures however displayed an exponential increase in fluorescence 
between 1 and 3-4 hours, reaching plateau after 4 hours at approximately 3 times the 
level seen in the uninduced cultures.   
 
Maximum specific growth rates, final OD values and yield coefficients were also 
determined, the results being tabulated in Table 4.6 below. 
Table 4.6) Summary of growth parameters of MG1655 (WT&  puvGFP) grown  in 
two different media and culture conditions. N.d = not determined 
Strain and Media  µmax (h-1) Xmax (g/l) Yx/glu (g/g) Yac/x (g/g) 
E.coli MG1655 WT LB shake 
flask 0.70 ± 0.087 2.92 0.73 N.d. 
E.coli MG1655 puvGFP LB 
shake flask uninduced 0.64 ± 0.095 2.80 0.67 N.d. 
E.coli MG1655 puvGFP LB 
shake flask induced 0.60 ± 0.022 2.78 0.67 N.d. 
E.coli MG1655 WT, M6 (STR) 0.71 ± 0.090 2.53 0.63 0.88 
E.coli MG1655 puvGFP, M6 
uninduced (STR) 0.63 ± 0.065 2.40 0.60 1.00 
E.coli MG1655 puvGFP, M6 
induced (STR) 0.59 ± 0.035 2.24 0.56 0.95 
E.coli MG1655 WT, M6 shake 
flask 0.62 ± 0.064 1.72 0.43 1.17 
E.coli MG1655 puvGFP, M6 
shake flask uninduced 0.56 ± 0.082 1.56 0.39 1.28 
E.coli MG1655 puvGFP, M6 
shake flask induced 0.55 ± 0.063 1.50 0.38 1.30 
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The comparison of all nine sets of data showed significant differences in growth 
rates between M6 shake flask cultures and M6 stirred tank reactors (T=6.70 > 1.943, 
95%, df. 6) and also between the M6 and LB shake flasks cultures (T=5.96 > 1.943, 
95%, df. 6). No difference was seen between the three conditions in any of the 3 
cultures. This showed that regardless of growth conditions the incorporation of the 
plasmid had no significant effect on growth parameters. However the trend was seen 
in each condition whereby maximum specific growth rates are seen to be reduced 
with the incorporation and subsequent induction of the recombinant protein. 
Significant differences in maximum biomass concentration were seen which 
followed the same trend seen for growth rates. It is a pattern of the data that wild 
type values were consistently higher than uninduced values, which were again 
higher then induced values however these differences were not statistically 
significant. Previously is has been stated that it was thought that this difference in 
growth rate might be causing the lack of expression control that can be seen in 
Figures 4.5, 4.6 and 4.7. A hypothesis explaining how a reduced growth rate could 
affect recombinant protein expression control is suggested and discussed in the 
following section. 
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4.11. Summary and Conclusions 
 
The aims of this section of work were to set up a model bacterial system where 
growth characteristics could be investigated for the MG1655 strain of E.coli 
containing a GFP producing plasmid in a number of culture conditions.  It also 
established a baseline for growth of E. coli MG1655 before and after transformation 
with the plasmid puvGFP that could be used for comparison throughout the project. 
To answer these aims a minimal medium was chosen that displayed moderate and 
reproducible growth in shake flask culture, which was designed to be limited in 
carbon source. HPLC analysis indicated that the cultures were carbon limited after 
ca. 7 hours of cultivation. This limitation was thought to be necessary to analyse 
mutants with deletion in genes of central metabolism. E.coli is known to 
demonstrate a remarkable level of plasticity when carbon flux is altered, by mutation 
for instance, (Almaas et al., 2004), and therefore a certain level of carbon stress was 
desired to make the physiological effects of any central metabolic deletion more 
easily observable.   
 
It is well recognised (e.g Seech & Trevors,  1991) that the incorporation of a plasmid 
constitutes a metabolic load to the cell, with the most often seen phenotypic effect 
being reduced maximum specific growth rate (e.g. Betenbaugh, 1987, Alldrick & 
Smith, 1983, Clerch et al., 1996). The data presented confirms this observation for 
two different types of media and two culture techniques, however there is a universal 
similarity in all cultures in that the apparent load (assumed by reduction in µmax and 
Chapter 4:  GFP recombinant strain as a model system  
 
 88 
Yx/glu) is greater between the plasmid free and the plasmid containing strain before 
induction than that apparent between uninduced and induced cultures of the plasmid 
carrying strains. 
 
This may not be an unsurprising result in the light of the plasmid protein expression 
vector system utilised. Referring to the plasmid construction (materials and methods, 
section 2.3) it can be seen that puvGFP is based on a pBR322 type plasmid 
containing an ampicillin resistance gene to allow selection for the successfully 
transformed cells and culture plasmid maintenance. The enzyme β - lactamase that 
confers resistance to penicillin-based antibiotics is constitutively expressed or 
antibiotic resistance would not occur. It can therefore be seen that the plasmid 
transformed strain is already expressing a foreign protein before any construct is 
induced. Therefore the slowing of growth rate between the plasmid free and plasmid 
uninduced strains can be attributed to the extra load of plasmid replication itself and 
also the production of β - lactamase. It is possible then that a smaller difference 
should be seen when a single extra protein is produced after induction but this will 
depend strongly on the expression level. Similar results were found by Roskov et. al. 
(2004) whilst attempting to describe changes in growth rate and overflow 
metabolism in a plasmid expressing strain of E.coli DH1. 
 
This extra protein production is seen in analysis of total intracellular protein. It was 
seen that at the beginning of stationary phase, plasmid carrying strains produced 
approximately 30% more protein than the wild type strain. However this was not 
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continued when recombinant protein production was successfully induced. As 
shown in Figure 4.8.1 the trend in increased total protein is also seen between the 
plasmid free and plasmid carrying strains in stirred tank reactors. When GFP 
production is induced, and confirmed by the increase in fluorescent signal no 
significant difference is observed in total protein production. It is thought that in 
bacterial cultures producing a foreign protein, some native protein production can be 
shut down to allow the cell to divert resources into the formation of the new product 
(Terpe, 2006). It is suggested that this is the reason for trends shown in the data here. 
 
The real interest however lies in the comparison of GFP expression based on 
fluorescence signals in different culture conditions. In the slow growing MG1655 
puvGFP in M6 medium in shake flasks; no significant difference was displayed 
between the uninduced and induced cultures. However, with the same medium 
growth rates increased by the use of stirred tank reactors and a marked difference 
was observed in GFP signal before and after induction with IPTG. The question was 
then raised whether this phenomenon was dependant on the growth rate or whether a 
feature of the reactor culture caused the results observed. A third set of experiments 
were then performed in shake flasks by using the complex Luria Bertani broth. Table 
4.10.1 shows the similarities in growth rates between the bioreactor culture using 
minimal media and the small-scale shake flask culture using LB. In addition, Figure 
4.10.1 shows a similarity of fluorescence profiles over the course of both 
fermentations. Taking together it may be concluded that the GFP induction is 
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affected by a decrease in growth rate regardless of other external variables. One 
hypothesis to explain this is based on the plasmid construct itself.  
 
Control of recombinant gene expression is based on the lacI gene. In the absence of 
lactose, or its analogue IPTG, Lac I is produced and binds to the operator in the 
lactose operon. This prevents DNA polymerase moving along from the promoter 
region and therefore, if a gene of interest is inserted downstream, can prevent 
transcription of the recombinant gene. However it is proposed that as plasmid 
replication is not linked to cellular division, slow growth may see a relative increase 
in copy number from the 20 copies per cell expected. As the number of plasmid 
copies increases the amount of lac I in the cell may be insufficient to block all of the 
lac operator sites and therefore this could allow transcription of the GFP construct 
downstream. At higher growth rates the plasmid copy number stays generally 
constant and therefore only the addition of IPTG or lactose will allow the gene 
product to be expressed. It was thought that this could explain the fact that control of 
GFP expression was only observed at the higher growth rates seen in the stirred tank 
reactors and complex media shake flask cultures (Ward, personal communication). 
 
In conclusion the results demonstrate the development of a robust model system to 
study recombinant protein production in E.coli. GFP was chosen as a convenient 
protein product due to its ease of detection and the plasmid system based on pBR322 
is a proven vector platform. The data showed that M6 medium could deliver 
adequate and predictable growth leading to carbon limitation after about 7 hours.  
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The issue of plasmid expression control was important to understand and the impact 
on further work assessed. As has been stated, no significant difference was seen in 
the level of GFP expression between the induced and uninduced cultures using 
minimal media and shake flasks. It was suggested that this may be as a result of slow 
growth rates seen in such cultures, a hypothesis that was borne out by results in 
faster growing cultures either in stirred tank reactors or using complex media in 
shake flask conditions. Although these results need to be noted the impact on this 
work and subsequent investigations were thought to be minimal. Relative levels of 
GFP production (measured by fluorescence) were seen to be equivalent in all three 
conditions, the differences being only found in uninduced cultures that were growing 
more rapidly. For future investigation this lack of expression control should be noted 
as a characteristic of growth in minimal media shake flasks but protein expression 
has been shown to be not significantly affected by the lack of a tight control on the 
promoter system. Therefore the plasmid and growth conditions were thought to  
provide a solid foundation for further investigation into heterologous protein 
production with differing host strains, which are described in the following chapter. 
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5.1. Introduction 
The following chapter describes the evolution of the model system developed in 
the previous chapter, in which the experimental set up was defined. It was shown 
that the strain of Escherichia coli MG1655 could produce a foreign protein 
through the incorporation of a plasmid vector and that, although it was thought 
the expression of the antibiotic resistance gene, the recombinant protein and the 
maintenance of the plasmid, caused a significant metabolic load, good growth 
and protein production was achieved. The phenomenon of uncontrolled 
expression in slow growing shake flask cultures was seen and an explanation put 
forward.  
 
Based on these results the following chapter looks to build on this platform of 
E.coli expressing recombinant protein utilising the parallel approach of low 
volume shake flask cultures but with a better understanding of their limitations 
and continuing to use a small number of stirred tank reactors for comparison. 
 
After reviewing results obtained in earlier chapters it was decided that as a 
progression of the work another protein target was required. This protein, namely 
N-methyl tryptophan oxidase (MTOX), was chosen as it was thought that the 
production and optimisation of the protein product, a member of an important 
group of enzymes, the flavoproteins, could have more potential benefit and may 
be of more use than GFP. Although GFP has many uses in molecular biology, 
and has proven itself to be a convenient protein to visualise and measure due to 
its fluorescent nature there is no commercial gain from designing a strain of 
E.coli that will overproduce the protein.  
Chapter 5:  Production of the flavoprotein MTOX in E.coli  
 
 94 
 
More important than the potential commercial interest in MTOX, it was noted 
that as MTOX was part of the group of flavoproteins found in many organisms 
there would be a specific pathway that could be targeted when mutant strains 
were chosen for the continuation of the study. 
 
The group of flavoproteins rely on the binding of a cofactor, namely FAD or 
FMN. As described in Chapter 1 (section 1.5), the initial thought that single gene 
deletions in central metabolism could be shown to have significant effects on 
recombinant protein production was questionable, therefore a more directed 
approach was sought. The fact that flavoenzymes require a flavin cofactor to be 
bound to confer activity allowed a directed approach to investigating gene 
deletions as an obvious pathway to explore would be that producing riboflavin 
and its derivatives. 
 
Further explanation of the rationale behind the move away from GFP and to 
MTOX is included in Chapter 1 including its potential uses in industry, structure, 
and function. However a brief overview will be included here for clarity. 
 
Flavoenzymes such as N-methyl tryptophan oxidase have a flavin group 
(commonly flavin adenine dinucleotide or FAD) covalently bound to them that 
alters the characteristics of their active site, conferring enzymatic activity 
(Hassan-Abdalah, 2005). This chapter therefore describes experiments designed 
to measure the amount of MTOX protein produced by a number of E.coli strains 
and also to determine the proportion of expressed protein that is active, i.e. has a 
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FAD moiety bound. It also presents data from characterisation of strains 
containing mutations in the riboflavin pathway. Again covered in the initial 
chapter, mutations in the pathway directly responsible for the production and 
recycling of riboflavin, FMN and FAD were expected to have some effect on the 
amount of FAD available to the cell to bind to MTOX and produce a viable, 
active enzymatic product. 
 
Various flavinated proteins exist and may prove to be industrially relevant. What 
was hoped was that information gained on the optimisation of production of one 
flavinated enzyme may be relevant to other proteins in the group as they all have 
the common necessity for FAD as their cofactor which confers activity. 
 
 
5.2. Initial growth characteristics of the new strains and constructs 
 
GSK donated a strain of E.coli (TG1) containing a MTOX expressing plasmid 
(pMEX8), which had been used previously for investigations into flavoprotein 
expression. However the planned modelling work and the mutant strategy, which 
are both explained in detail elsewhere, required the use of a K-12 strain such as 
MG1655. To this end a second plasmid construct was developed in house and 
was named pQR498, (for details see Chapter 2, section 2.3). Also although data 
was collected for strains in both M6 media and LB, the latter was used for much 
of the analysis due to the ability to control expression under conditions 
supporting faster growth. As the new plasmid was developed from puvGFP 
plasmid initial experiments sought to compare the growth rates of the 3 different 
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strain/construct combinations in use. The comparative growth rates are shown in 
Table 5.1 below. 
 
 
Table 5.1) Comparison of maximum specific growth rates of 3 strain/plasmid 
combinations grown in SFs in LB medium (data includes n = 6 independent 
replicates) 
 
 
 
 
 
 
 
No significant difference was seen between the MG1655 pQR498 and MG1655 
puvGFP constructs (induced) retuning a value of 0.0 with a one tailed test (Pcrit 
= 2.132, 95%, d.f.=4). This was expected as only the gene expressed was 
changed between the two constructs. 
 
No significant difference was also seen in the induced state between the two 
different strains containing the same plasmid (pQR498), returning a value of 0.54 
again less than the critical value of 2.132. 
 
Finally no significant difference was seen when induced between either strain 
containing the other plasmid. GSK supplied a TG1 strain transformed with 
pMEX8; pQR498 being initially developed in MG1655. Thus it was shown a 
TG1 strain transformed with pQR498 would behave similarly to a MG1655 
Strain and Media  µmax (h-1) 
E.coli MG1655 pQR498, LB uninduced 
E.coli MG1655 pQR498, LB induced 
E.coli MG1655 puvGFP, LB uninduced 
E.coli MG1655 puvGFP, LB induced 
E.coli TG1 pMEX8, LB uninduced 
E.coli TG1 pMEX8, LB induced 
0.64 ± 0.032 
0.62 ± 0.024 
0.64 ± 0.095 
0.62 ± 0.022 
0.67 ± 0.040 
0.61 ± 0.018 
E.coli MG1655 pMEX8, LB uninduced 
E.coli TG1 pQR498, LB uninduced 
 
0.66 ± 0.056 
0.67 ± 0.089 
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strain containing pMEX8. The T test returned a result of 0.1 (<2.132). 
Comparable values of growth rates are seen in both strains showing no bias to 
either plasmid construct. 
 
5.3. Peroxide assay: Initial findings 
As explained in Chapter 2, an assay was developed for the measurement of 
MTOX activity using the demethylation of N-methyl L-tryptophan to producing 
hydrogen peroxide as a by-product allowing colourimetric detection of peroxide 
to act as a signal for the presence of the enzyme. 
 
With this reaction as the basis of the assay, specific units of enzyme production 
are difficult to calculate as there was no direct measure of enzyme concentration, 
only activity. Further work was undertaken in later fermentation runs that 
measured directly the amount of MTOX produced which could be related to 
activity to calculate specific activity. In the earlier work a simpler method was 
employed to gain a quick insight into the production of the enzyme. The method 
for quantification is explained in section 2.4 of materials and methods. For the 
following work some data is presented as concentration of peroxide evolved and 
some in Units of activity. 
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Figure 5.1) Comparison of peroxide production for MG1655 pQR498: LB and 
TG1 pQR498: LB in shake flask cultures (Time is pre/post induction with IPTG 
at time = 0, n = 6 independent replicates) 
 
 
Initial work (in Figure 5.1) showed that, as expected, the amount of peroxide 
produced increased over the time of the fermentation. The first experiment also 
showed lack of control of the promoter system, as peroxide levels increased 
significantly from baseline throughout growth without the presence of IPTG as 
an inducer.  
 
The first comparison was made between MG1655 and the TG1 strain (see Figure 
5.1. The graph shows time point -1 or one hour prior to induction, this was 
commonly the point the cultures were seeded but not exclusively. Following this, 
data collected 1, 3 and 5 hours post induction are shown. A marked difference 
between the two strains was seen. MG1655 was seen to exhibit low levels of 
MTOX activity, which increased steadily up to a maximum at 5 h post induction. 
TG1 however showed similar levels of activity 1 h after induction but then 
activity increased dramatically to a final level over 4 times that of MG1655. On 
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examining these results further investigations were thought necessary to form a 
more complete picture of MTOX production and activity in the cell. 
 
5.4. Peroxide assay development 
There were a number of questions that arose from the early MTOX assay work, 
the most important involving the activity of the enzyme itself. 
 
As described in the introduction, MTOX, like all flavoproteins requires a change 
in conformation of its active site caused by the covalent binding of FAD, to 
confer activity. The assay therefore, by definition, was only measuring the active 
or holo enzyme. Work by Hassan – Abdallah (2005) showed that although 
enzyme activity is severely reduced in the absence of FAD, activity could be 
recovered in over 90% of protein molecules with the addition of FAD into 
solution. 
 
With this as a basis it was decided that the assay should be repeated, with FAD 
added to one set of samples before analysis as described in Chapter 2 section 2.5. 
The hypothesis being any apo forms of the enzyme produced by the host would 
be converted to the active holo form and then become detectable by the assay 
technique. Data could then be produced comparing the total amount of enzyme 
produced originally and the proportion of that enzyme that was active at that 
time. 
 
Chapter 5:  Production of the flavoprotein MTOX in E.coli  
 
 100 
Other controls/assay developments were investigated, firstly including a short 
study investigating the minimum amount of FAD that could be added to give full 
conversion, secondly a cell breakage experiment to ensure the lysis conditions 
developed in Chapter 3 were indeed the most efficient at cell disruption and 
thirdly collection of data from later than 5 h post induction (generally 6 – 7 hours 
culture time) to confirm enzyme production did not continue to rise after 
stationary phase was reached. These are covered in detail in Chapter 3, “Method 
development”. 
 
Initially the conditions from the above experiment were revisited. Taking the 
sample from 3h post induction on Figure 5.1 and analysing with and without 
FAD addition the following was seen. 
 
 
Figure 5.2) Comparison of MTOX activity (measured by peroxide production) in 
two strains of E.coli before and after addition of FAD (100µM) 
 
 
It was noted that although the levels of MTOX enzyme activity was still greater 
in the TG1 strain the total amount of protein produced, irrespective of its activity, 
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was comparable between the two strains. The difference is significant between 
MG1655 with 100µM FAD added and TG1 with the same addition at the 95% 
level returning a result of 20.73 (> 2.132: df=4). It was therefore suggested that 
the TG1 strain has a greater pool of cellular FAD or a greater capability to supply 
FAD on demand than the MG1655 strain; this will be discussed further at the end 
of this chapter (section 5.11) 
 
The hypothesis was then put forward that a host strain producing more FAD or 
having the capability to supply more FAD would not necessarily produce more 
MTOX protein but a greater proportion of that protein would be the holo or 
active form. 
 
Before the mutant strategy was pursued, an easier option was considered. A 
cheap and convenient solution to the problem of supplying FAD may be to grow 
the strains on a media enriched with a FAD precursor such as riboflavin.  
 
 
5.5. Growth on riboflavin enriched media  
Riboflavin was added to LB media at a concentration of 1mM and the two 
comparative fermentations described in section 5.3 and 5.4 repeated in this 
medium. Riboflavin was used in favour of FAD in that it is relatively stable in 
solution and considerably less expensive than FAD. A industrial process with a 
riboflavin enriched media was thought to be economically viable where an FAD 
enriched media would not be. 
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Figure 5.3) Comparative enzyme activity (measured by peroxide production) in 
two strains of E.coli using riboflavin enriched (1mM Riboflavin) media (n = 6 
replicates) 
 
 
No significant differences were seen between the media enriched with riboflavin 
and that without, whether induced or not induced. What this shows about cellular 
adsorption of riboflavin is discussed later (section 5.11) but what is clear is that 
the production of a FAD dependent enzyme cannot simply be improved by 
growth on a rich riboflavin medium. This was an important control experiment as 
it gives a basis for completing the more complex deletion mutant utilising 
strategy that will be detailed in the continuation of this chapter. It has been 
shown that the simple act of enriching growth medium does not lead to an 
increase in active MTOX production therefore other avenues needed to be 
explored. 
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5.6. Development and expansion of an experimental matrix 
 
In response to the expanding nature of the plasmid, strain, media combinations a 
simple matrix was designed to better track the growing number of experiments 
carried out. An example of this matrix is included in Appendix 1.  
 
The aim of much of the work was then altered to investigate the level of active 
enzyme production in a small number of deletion mutants from the Mori 
collection (Mori et al., 2000). As discussed in the introduction (section 1.5) three 
K-12 E.coli strains were used, MG1655 as discussed in Chapter 3, W3110 and 
BW25113 (used as host in the Mori collection). Mutations from the E.coli wild 
type are noted in section 2.2 of the materials and methods chapter. 
 
The comparison between the first three strains was not only important for the 
protein production work but also the modelling work, which is described in the 
following chapter. Therefore, before any extended experimental plan was made, 
a short bridging study was undertaken to ensure similar growth was seen in 
W3110 and BW25113 before transformation with the plasmid construct 
pQR498, and then that similar levels of MTOX protein was produced both before 
and after induction. 
 
The data from the study is summarised in Table 5.2  and shows no significant 
differences between any of the strains in any of the conditions investigated. On 
the basis of these results it was decided that earlier data generated with the 
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MG1655 strain would be comparable with the related strains, W3110 and 
BW25113 that would be used increasingly in the continuation of the work. 
 
Table 5.2) Comparative growth rates and MTOX protein production for three 
strains of E.coli used in the study 
Strain and Media µmax (h-1) 
Xmax 
(g/l) 
Units of 
MTOX 
activity 
(pre FAD) 
Units of 
MTOX 
activity 
(post FAD) 
E.coli MG1655 uninduced 
LB shake flask 0.64 ± 0.1 2.8 0.002 0.003 
E.coli MG1655 induced  
LB shake flask 0.60 ± 0.02 2.78 0.71 2.4 
E.coli W3110 uninduced  
LB shake flask 0.66 ± 0.1 2.97 0.004 0.006 
E.coli W3110 induced LB 
shake flask 0.64 ± 0.2 2.78 0.77 2.3 
E.coli BW25113 
uninduced LB shake flask 0.64 ± 0.3 2.66 0.003 0.004 
E.coli BW25113 induced 
LB shake flask 0.64 ± 0.4 2.59 0.86 2.7 
 
 
As described in the materials and methods, units of activity in this context refers 
to a measurement of MTOX activity defined by the rate of peroxide production. 
Wagner describes this rate as “One unit of activity being…the formulation of 
1µM peroxide/min at 25°C following standard assay procedures”. Prior to 
analysing the protein makeup of the cell lysates via SDS-PAGE this 
measurement was used to give an accurate measure of the level of expression and 
activity of the MTOX enzyme. 
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5.7. Mutant strategy 
 
The strategy for selection of single gene deletion mutants is described elsewhere,  
(Chapter 2.2.3) and the use of mutants lacking the genes, appA, cobB and cobT 
explained. 
 
The emphasis now altered from evaluating differences in growth rates caused by 
the incorporation of the plasmid as it had been shown that, TG1 aside, all host 
strains grew at approximately similar rates and produced comparable amounts of 
MTOX protein with statistically equal amounts of the active and inactive forms 
expressed.  
 
The initial work calculated the enzyme activity over triplicate shake flask 
fermentations for 7 strains with samples taken at 1, 3 and 5 hours post induction 
with a final value stating enzyme activity after adding 100µM FAD to the final 
sample (5 hours post induction). This then gave not only a maximum enzyme 
activity at the end of fermentation, but also the proportion of enzyme bound with 
FAD at that time. 
 
The data from these initial experiments is presented in Table 5.3. 
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Table 5.3) Units of MTOX activity for seven E.coli strains carrying the pQR498 
plasmid (with the exception of the wild type control, BW25113)(all figures are 
dimensionless) 
 
 
Time points  
Strain 1h ±SE 3h ± 5h  ± 
Final (+ 
FAD) ± 
MG1655 
pQR498 0.38 0.020 0.67 0.040 0.71 0.057 2.44 0.034 
BW25113 
pQR498 0.44 0.034 0.79 0.056 0.86 0.099 2.68 0.100 
appA 0.20 0.010 0.47 0.023 0.49 0.050 1.84 0.076 
cobT 0.75 0.044 1.57 0.089 1.70 0.077 2.78 0.099 
cobB 0.54 0.001 1.14 0.032 1.20 0.085 2.92 0.050 
TG1 pQR498 1.12 0.089 2.07 0.076 2.10 0.053 3.00 0.089 
BW25113 wt 0.001 N/A 0.002 N/A 0.002 N/A 0.003 N/A 
 
 
 
Observing the data, the trend shown in Figures 5.1 and 5.2 is underlined with the 
TG1 strain producing a higher enzyme activity at the end of fermentation before 
the addition of FAD when compared to the MG1655 strain. 
 
All other strains (coming from the Mori collection) are based on BW25113 and 
part of the data generated in the bridging study mentioned in section 5.6 is 
included. From this no significant difference can be seen between the MG1655 
and BW25113 strains carrying the plasmid, in terms of initial enzyme activity, 
the figure of 0.65 being calculated from the T-test (<2.132, 95%: d.f.=4). Also 
the capacity for enzyme production (when flooded with FAD) seems alike as the 
T-test returns a value of 1.12, again a non-significant result. 
 
Further analysis of the data was deemed unnecessary, as the aim was to generate 
a specific activity by combining the data above with information on the total 
amount of MTOX protein produced in each strain. 
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In light of this and following the peroxide assay findings, gels were run (as 
described in the materials and methods) with the clarified lysates from time 
points 1, 3 and 5. A protein standard of BSA (66.4 kDa) was used and total 
MTOX protein concentration of the lysates could be calculated using the 
standard curve generated. This data (quoted in mg/mL) is shown in table 5.4. 
 
Table 5.4) MTOX protein concentrations in clarified lysates of 3 separate E.coli 
strain fermentations (mg/mL) 
 
Time points  
Strain 1 ± 3 ± 5 ± 
MG1655 
pQR498 2.00 0.120 3.47 0.170 4.12 0.090 
BW25113 
pQR498 2.30 0.189 3.99 0.108 4.54 0.177 
appA 1.24 0.111 2.57 0.011 3.22 0.990 
cobT 1.87 0.078 3.55 0.123 4.67 0.200 
cobB 1.67 0.065 3.01 0.189 4.89 0.199 
TG1 pQR498 2.00 0.098 3.67 0.077 4.98 0.077 
BW25113 wt N/A N/A N/A N/A N/A N/A 
 
 
With these two sets of data it was therefore possible to calculate a specific 
activity for each of the protein expressing strains in terms of Units of activity 
(table 5.3) per milligram of MTOX protein present (Table 5.4). This calculation 
produced data that was truly comparable across all strains as it is displayed in 
specific units of activity, units/mg. 
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Table 5.5) Specific units/mg  of MTOX activity over all E.coli strains 
 
Time points 
Strain 1 ± 3 ± 5 ± 
Final (+ 
FAD) ± 
MG1655 
pQR498 3.78 0.303 3.84 0.298 3.44 0.287 11.86 0.305 
BW25113 
pQR498 3.83 0.432 3.98 0.301 3.78 0.207 11.81 0.439 
appA 3.23 0.331 3.63 0.180 3.01 0.324 11.43 0.591 
cobT 8.02 0.577 8.85 0.588 7.29 0.454 11.93 0.622 
cobB 6.47 0.252 7.58 0.521 4.90 0.401 11.94 0.713 
TG1 pQR498 11.20 1.046 11.25 0.477 8.42 0.250 12.05 0.430 
BW25113 wt N/A N/A N/A N/A N/A N/A N/A N/A 
 
 
The data shows some interesting trends with the six strains falling into two 
distinct groups in relation to specific MTOX activity.  
 
Firstly it was noted that the capacity for active MTOX production was not 
significantly different across the range of mutants. Although it has been shown 
(in Tables 5.3 and 5.4) that there were significant differences in the amount of 
holo enzyme between a number of the mutants, after the addition of FAD the 
differences became noticeably smaller underlining what was seen early in the 
investigation and shown in Figure 5.2.  
 
Apart from the appA mutant all strains showed equivalent levels of total MTOX 
protein production at the end point of the fermentations. Differences were 
observed where MG1655, BW25113 and BW25113 appA (hereon referred to as 
group 1) displayed levels of specific activity ca. 30% below the maximum 
activity, calculated from the samples with FAD added prior to assay. In 
comparison cobT, cobB and TG1 (group 2) displayed activity between 41 and 
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70% of the maximum level throughout the relevant cultures. Another feature of 
the fermentations seemed to be that for group 1, specific activity seemed constant 
over the time course of the fermentation. Group 2 however displayed very high 
levels of specific activity early on in culture growth, which seemed to drop late 
on in the fermentation. Potentially this data suggests Group 2 has a higher 
capacity for supplying FAD and conferring activity on the MTOX protein 
produced but that this supply is becoming limiting towards the end of 
fermentation where MTOX levels are highest. Group 1 strains showed a 
generally more stable specific level of activity suggesting although activity is 
lower; any feedback mechanisms used to replenish cellular FAD are adequate to 
meet the demand put on them. Little is known about the specific mechanisms of 
regulation of the riboflavin pathway in prokaryotes but it has been suggested that 
a type of feedback mechanism may be in place utilising an ancient piece of 
cellular machinery known as the riboswitch, (Vitreschek, et.al, 2004). 
Riboswitches are thought to regulate a number of systems; riboflavin and 
thiamine metabolism as examples, by undergoing conformational changes when 
bound to effector molecules. It is thought that this change often triggers the 
transcription of an mRNA coding for either a biosynthetic or transport protein 
that increases the level of the relevant metabolite (Fischer et al., 2005). 
 
In the data presented in Figure 5.5 below there is a noticeable rise in the levels of 
intracellular FAD after the induction of MTOX in all but one of the host strains. 
This may well be evidence in the experimental data collected for some kind of 
FAD feedback mechanism although whether this is linked to a riboswitch is 
unknown. 
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One important observation is that one of the chosen mutant strains (cobB) 
seemed to be able to compete with the TG1 strain in terms of MTOX activity 
throughout the course of the culture. Possible reasons for this are discussed later 
(section 7.3) in the light of further investigational work. 
 
 
5.8. FAD analysis of all strain samples 
 
Fermentations were carried out with all six strain/mutant combinations 
previously used and samples taken at various time points throughout growth. 
Figure 5.4 below summarises the results from these fermentations for each strain 
without plasmid and with plasmid both uninduced and induced. The data 
presented is from the mid exponential phase of all cultures, therefore 3-4 hours 
into the fermentations. 
 
Figure 5.4) Comparative plot of FAD levels in mid exponential phase samples(3-
4 h of fermentation) of 6 E.coli strains (n = 6 replicates) 
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The data gives a clearer picture of the two groups of cultures as described in 
section 5.7 of this chapter. Examining the first set of data for the plasmid free 
strains it was clear MG1655, BW25113 and the appA mutant all contained 
significantly lower amounts of unbound intracellular FAD than the TG1 strain 
and the cobB and cobT mutants. No significant differences were seen throughout 
the two groups themselves. 
 
There were also no significant differences in any value comparing plasmid free 
and uninduced, which was expected. After the induction of the plasmid and 
expression of the MTOX protein, FAD levels drop significantly in the TG1, 
cobB and cobT mutants again as may have been expected in light of the findings 
in section 5.7. These three strains showed a significantly higher level of enzyme 
activity without a significant increase in the actual level of MTOX expression. 
This suggested that a greater proportion of MTOX in these strains is bound to 
FAD and therefore active. The finding that free FAD levels are elevated in cobT, 
cobB and TG1 strains of E.coli is therefore an expected one. Although there was 
a general trend of a slight decrease in FAD concentration in the MG1655, 
BW25113 and appA, these losses were too small to be significant. 
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5.9. HPLC analysis over fermentation time courses 
 
Once the HPLC method was established shake flasks fermentations were run 
with more frequent sampling time points to establish a profile of cellular FAD 
levels over the course of a 6 – 8 hour fermentation. 
 
 
Figure 5.5) Free intracellular FAD levels (normalised to Biomass conc.) in 5 
strains of E.coli over the first 6 hours of MTOX fermentation (arrow indicates 
induction at T = 1 h with 1mM IPTG) 
 
 
A pattern was seen in intracellular FAD levels seemingly in agreement with 
earlier data. All strains increased the level of free FAD available in the cell from 
the time the seed culture was introduced into fresh media (T = 0) until induction 
via IPTG added at T = 1. During the first hour of MTOX production FAD levels 
were depleted in all strains, however all except the BW25114 appA mutant 
increased FAD levels during the following hour suggesting a strong feed back 
system to be present. 
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After this initial increase and the continuing demand for FAD the two groups as 
described in section 5.8 were seen to differ. Although the profiles of FAD levels 
were similar in all strains TG1, cobB and cobT were all seen to contain higher 
initial levels of the cofactor, which increased with cellular growth until MTOX 
induction. This caused a drop in free FAD as it bound to the protein which 
partially recovered 2 hours after induction. However levels then decreased 
gradually for the rest of the fermentation. 
 
The MG1655 and appA strains also showed an increase in FAD levels before 
induction and a reduction after, however the recovery was significantly slower in 
appA and seemed to plateau at approximately 0.5 µM FAD/OD 600nm.  
MG1655 reached this plateau 1 h after induction, the level of FAD being 
constant throughout the rest of the fermentation. 
 
 
5.10. MTOX production in 5L stirred tank bioreactors and comparison 
with SF fermentations  
 
As was the case in chapter 4 a small number of 5L stirred tank fermentations 
were undertaken to determine any differences from the previous data set caused 
by the differing culture conditions. For the comparison only 3 strains were 
investigated and all were induced at 1 hour after the addition of the seed culture 
into the reactor vessel. The three strains thought to be most interesting after 
reviewing data from the shake flask fermentations were the original MG1655 
strain containing the pQR498 plasmid as much of the baseline data was 
generated with this construct. Secondly the TG1 strain was used as a comparison 
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as it was the only non-K12 strain in use throughout the work. Finally the cobT 
mutant strain of BW25113 carrying the pQR498 plasmid was used as it proved to 
be the most effective construct for the production of MTOX in the shake flask 
experiments. 
 
Table 5.6) Comparison of 4 parameters related to MTOX production in 3 strains 
of E.coli under stirred tank and shake flask conditions 
Strain and Media µmax 
(h-1) 
Mean 
Units of 
Activity  
Mean 
Specific 
activity 
Mean FAD 
level (µM) 
E.coli MG1655 pQR498 (STR) 0.64  0.77 ± 0.10 3.78 0.06 ± 0.01 
E.coli TG1 pQR498 (STR) 0.67  2.41 ± 0.25 10.55 0.15 ± 0.03 
E.coli BW25113 cobT (STR) 0.65  1.74 ± 0.20 8.43 0.09 ± 0.04 
E.coli MG1655 pQR498 (SF) 0.56  0.58 ± 0.05 3.69 0.04 ± 0.01 
E.coli TG1 pQR498 (SF) 0.58  1.76 ± 0.44 10.29 0.10 ± 0.02 
E.coli BW25113 cobT (SF) 0.55  1.34 ± 0.29 8.05 0.07 ± 0.01 
 
From the data obtained a pattern is clear although statistical analysis was 
impossible due to the small sample population size, all stirred tank data was 
generated from n = 2 independent runs and all shake flask n = 6. The trends seen 
match those also shown in section 4.10 where a significant difference in growth 
rates was seen between shake flask cultures of E.coli and stirred tank 
fermentations. All three strains exhibit faster growth under stirred tank 
conditions when compared to small-scale shake flasks.  
 
Relevant to MTOX production three other parameters are compared. Firstly the 
units of activity of MTOX enzyme, averaged over the course of the fermentation 
(1, 3, 5 and 7 hours after induction). These show an increased enzyme production 
in stirred tanks as expected due to the faster growth and higher final biomass. 
Specific units of activity are therefore quoted with the figures normalised by the 
amount of total MTOX protein produced. These figures show a minimal increase 
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in specific MTOX production over the two fermentation regimes suggesting 
specific MTOX production may be more strain specific than growth rate/regime 
specific. 
 
The cellular FAD levels seem to be consistently higher in the stirred tank 
fermentations, although as stated above the sample size prevented any statistical 
analysis of the data, however this may be expected with the cells being in a less 
stressed state than seen in shake flask cultures (possibly due to poor pH control, 
poor oxygenation or other drawbacks of the culture technique (Anderlei, et al., 
2001, Garcia-Arrazola et al., 2005, Büchs, 2001). It is this increased level of 
intracellular FAD that may account for the increased levels of MTOX activity, 
however it seems that the amount of FAD that can be bound as a cofactor is 
determined not by the level of FAD available but is strain specific. 
 
5.11. Summary and Conclusions 
 
A natural progression from model system to a group of products with greater 
potential for commercial interest and also the opportunity to investigate factors 
affecting many cofactor- requiring enzymes was the driving force behind the 
switch from GFP to the MTOX protein. It was possible to determine the impact 
of the host strain on the supply of cofactors and whether different levels of 
cofactors, or their precursors, in the cell could affect active enzyme production. 
 
As a comparison, initial experiments were similar to those run for the GFP 
construct. Maximum specific growth rates were calculated from measurements 
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of optical density over time for a number of strain/plasmid combinations. No 
significant differences in growth rates were seen in MG1655 or TG1 expressing 
either the pMEX8 or pQR498 plasmid constructs proving no plasmid bias in the 
testing. Also equivalent values were obtained for the pQR498 and puvGFP 
constructs as expected considering the only change was the protein of interest. 
 
Without a conveniently fluorescing protein product, an assay was developed to 
measure the activity of the expressed MTOX enzyme, reliant on its ability to 
demethylate methyl tryptophan producing peroxide that could be measured, this 
is covered in more detail in chapter 2. 
 
Initially a low level of constitutive expression was seen but upon induction raised 
levels of enzyme were measured in both strains starting from a low level early in 
fermentation to relatively high levels 5 – 7 hours post induction. The TG1 strain 
showed a level of enzyme production initially 4 times that of MG1655 but it was 
quickly realised that the assay, as performed, would only be measuring active 
enzyme and may be insensitive to large amounts of expressed protein present but 
without the FAD moiety bound conferring activity. 
 
In answer to this problem the assay was improved to measure the amount of 
active enzyme as a proportion of total enzyme present, which gave some 
interesting findings. The large difference in protein levels seen in figure 5.1 
between MG1655 and TG1 was much reduced when total enzyme was assayed. 
Although TG1 was still producing significantly more MTOX protein than 
MG1655 it was shown that the latter had produced similar amounts of the 
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enzyme but the majority of this protein being in its inactive form. This suggested 
either TG1 had a larger capacity for storing FAD or that it may react faster to a 
demand for FAD than MG1655. Work has been done on what is known as the 
Rib operon (Mack et al, 1998) and also the role of flavokinases for the 
conversion of riboflavin to FAD/FMN (Bacher, 2001) but little has been written 
on the differences seen in FAD supply in different strains of the same organism. 
 
On this basis, and after exploring the possibility that a simple enrichment of the 
culture medium with riboflavin proved ineffective, the Mori collection (Mori, et 
al., 2001) was searched for deletion mutants deficient in genes thought important 
to the production of riboflavin or its conversion to FAD.  
 
Three deletion mutants were chosen for further study based on three important 
genes in the Riboflavin pathway, appA, cobB and cobT. The choice is discussed 
in Chapter 1. 
 
With the increasing number of strains/mutations it was important to have a 
robust method of comparison between results. The chosen method is fully 
described in Chapter 2 section 2.4.5 and allowed direct comparison of enzyme 
production in each strain. The results showed two distinct groups; MG1655, 
appA and BW25113 all showed low levels of specific activity as shown in Table 
5.5 and the cobT, cobB and TG1 strains that displayed significantly higher levels 
of enzyme activity than this first group. This then suggested a direct link between 
MTOX activity and the supply of FAD in the cell. Although directly enriching 
the growth media had no impact on enzyme activity (see section 5.5) it seems the 
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intracellular level of FAD can have a direct impact on protein activation in this 
case.  
 
MG1655 and BW25113 were both unaltered host strains compared to appA 
(deficient in the enzyme catalysing the back conversion of FMN to riboflavin), 
and cobB and cobT (both involved with the degradation of riboflavin into 
ultimately vitamin B12 (Fischer, et al., 2002)). Therefore an HPLC method was 
developed to directly measure the amount of FAD in the cell at specific times 
throughout the fermentations and also discriminate it from riboflavin and FMN. 
 
Although the method was shown to have some drawbacks, most notably the low 
level of spiked FAD recovery (see method development chapter) it underlined 
the differences discussed above clearly. The low producers of active MTOX 
(MG1655, BW25113 and the appA mutant) all had very low levels of FAD 
available at mid exponential phase (see figure 5.4) compared to the much greater 
values determined for the TG1 strain and cobB and cobT mutants. The amount of 
FAD remained roughly constant for those strains producing mainly apo enzyme 
regardless of the level of expression seen (Group 1). Those strains that were 
producing mainly holo enzyme (Group 2) however displayed a dramatic drop in 
the level of free FAD when MTOX was expressed. Useful as this snapshot was, 
multiple samples were then taken throughout the time course of the 
fermentations the aim being to see how FAD levels fluctuate over an MTOX 
producing culture. 
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As shown in Figure 5.5 the holo enzyme producing group saw a sharp increase in 
FAD levels between the time seed cultures were added until protein expression 
was induced at t = 1.  Following that there was a sharp decrease until presumably 
a feedback mechanism such as the riboswitch suggested by some (Vitreschek, 
et.al, 2004) registers a lack of FAD (Mack. et al. 1998) and levels started to 
recover. From that point on however MTOX is still being produced and is still 
utilising the supply of FAD, therefore after 3 hours there was a steady decline in 
FAD levels until a plateau at about 0.08 µM for TG1 and cobT or 0.06 µM for 
cobB was reached. Whether this is a baseline level of FAD specific to each strain 
is unknown however it does seem to support the slight differences seen in 
specific activity seen at the end of fermentation in the cobB and cobT strains (see 
Table 5.5). In comparison the MG1655 strain follows the same pattern of 
increase, use, feedback but then quickly reaches a plateau significantly lower 
than any of the holo enzyme producing strains. The appA mutant is the only 
exception to this profile displaying a much elongated feedback recovery. It is 
feasible the deletion in the FMN – riboflavin back reaction may have affected the 
ability of the cell to react to a FAD demand. This result was not investigated 
further but may be of interest in future studies. 
 
Finally a small number of fermentations were carried out in 5L stirred tank 
reactors for comparison with the above data from shake flask cultures. Although 
insufficient runs were completed to be analysed statistically they provide a useful 
insight. As shown in chapter 4, maximum specific growth rates were expected to 
be higher in the stirred tank experiments than in shake flasks. Potentially linked 
to this faster growth and a higher final biomass level the mean enzyme activity 
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over the culture time was increased compared to the shake flask runs. Following 
this trend mean levels of FAD were also increased. However, the mean specific 
enzyme activity was essentially unchanged over the life of the culture. 
Regardless of FAD levels or amount of enzyme produced, specific levels of 
active enzyme remained fairly constant for each strain. 
 
In conclusion it has been shown that levels of active MTOX enzyme can be 
increased by the use of certain host strains or specific deletion mutants in the 
riboflavin pathway. TG1, a strain that has been used in the past for recombinant 
protein production studies (Hoffmann and Rinas, 2004) showed high levels of 
FAD and subsequent high levels of active enzyme produced. For the mutant 
strains the activity of cobT and cobB mutants was interesting as they both 
displayed similar levels of free FAD and consequentially similar levels of active 
MTOX enzyme as TG1. 
 
The function of cobT is to synthesise the lower ligand of vitamin B12 (Chen,  
1995) encoding the enzyme 5,6, dimethylbenzimidazole (DMB). cobB codes for 
a phosphoribosyltransferase also involved with vitamin B12 production. 
However Chen (1995) stated cobB seems to require a high concentration of 
DMB for activity. He went on to say that cobT has been seen to possess some 
ability to transfer ribose phosphate, as well as cobB.  
 
In light of this work the small differences in the cob mutants could be explained. 
In the case of the cobT mutant DMB is not produced and although cobB will 
produce phosphoribosyltransferase this will function with a lowered activity. 
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Thus carbon flux should be massively reduced downstream of riboflavin 
allowing the cell to partition more into the production of FAD, and therefore 
resulting in the higher specific activities seen in Table 5.5. In the case of the 
cobB mutant, it would seem cobT may take the role of both enzymes and 
although this may result in a partially reduced carbon flux through to B12 this 
reduction should be significantly less than in the previous case, specific activities 
are therefore increased with respect to the non-mutant strains but to a lesser 
degree. 
 
As has been said, the appA mutant has no direct effect downstream of riboflavin 
and as such will not affect flux towards B12. Whether the removal of this 
enzyme reduces the ability of the cell to respond to lower FAD levels is a 
hypothesis put forward but not proven currently.   
 
The above work therefore formed a significant data set describing growth, 
MTOX production and cellular FAD levels in a number of E.coli strains and with 
differing culture conditions. This was then used as an experimental basis for 
comparison with model data generated using the Palsson E. coli reaction network 
(Edwards & Palsson 2000, Wilback et al., 2004, Feist et al., 2007) and also 
investigating how increase in growth rate or intracellular FAD concentrations 
could alter the expression and activity of the MTOX recombinant protein 
product. The use of the model network and its comparison with laboratory-
generated data is discussed in the following chapter. 
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6.1. Introduction 
 
 
The metabolic model of E.coli used in the following work (Edwards and Palsson, 
2000) was first developed by Palsson’s group in 1990 and consisted of 695 genes, 
coding enzymes responsible for 720 individual reactions involving 436 metabolites. 
This in turn is based on published information about the annotated genome sequence 
of the K -12 strain of E.coli MG1655 (Blattner, 1997) and other physiological and 
biochemical information. 
 
Metabolic modelling is becoming more prevalent and with the development of more 
sophisticated models, is becoming an important tool in metabolic engineering 
research. The benefits are clear, in that once a model is created and its designers are 
confident it can behave in a way comparable to the organism under experimental 
conditions, it can be used to perform many in silico investigations in a matter of 
hours, work which in the traditional laboratory may take days or even months. 
 
It is partly for this verification, that the model is included in this work. The model 
can generate carbon fluxes (e.g. to biomass, to a specified protein, or to another 
metabolite), which can be directly related to information gained in the laboratory 
environment. A good level of agreement between the experimentally and 
computationally derived data would allow a greater level of confidence in 
predictions made by the model when investigating other reactions. 
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As previously stated, the model is based upon 720 reactions found in MG1655, 
therefore initial work was needed to adapt the reaction network to allow for gene 
deletions introduced in BW25113 (the strain that is the basis of the Keio collection) 
not present in MG1655. This was achieved by the removal of pathways in the model 
relating to gene deletions in the BW25113 mutants employed. 
 
Following this it was possible to include the stociometric equation for the production 
of MTOX (see Appendix 2) and search for solution spaces using linear programming 
techniques that would maximise the production of the protein or maximise biomass 
production. As the model included the reaction networks responsible for the 
riboflavin pathway (detailed in Chapter 1), it was also possible to calculate the flux 
into FAD and how that might change when the other 2 output variables were altered. 
It was also possible to alter the carbon uptake rate and thereby constraining the 
model. This input variable could also be calculated from experimental work relying 
on the HPLC analysis of organic acids to determine the rate of carbon utilisation in 
vivo. 
 
Finally the data generated was compared to the experimental data and any 
discrepancies discussed. 
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6.2. Effect of growth rate on MTOX and FAD fluxes 
 
Firstly the relationship between cellular growth and MTOX protein production was 
explored. A range of specific growth rates up to a maximum suggested by the model 
constrained by the glucose uptake rate were used and the corresponding flux of 
carbon into MTOX was calculated. 
 
 
 
Figure 6.1) Plot of specific growth rate vs specific MTOX production rate predicted 
by the BW25113 model reaction network add glucose uptake rate used to constrain 
model 
 
The model predicts that as the rate of growth increases the flux of carbon into the 
production of MTOX decreases approximately linearly to a point where maximum 
specific growth rate is approximately 0.5 h-1, where no more MTOX is produced. 
This was based on the assumption of a glucose uptake rate of 6.6 mM/g(DCW)/h 
which was calculated from experimental data described in Chapter 5. 
Growth Rate (µMax) 
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A second scenario was examined with no growth but estimating the possible 
maximum flux to FAD given a certain flux to MTOX. This simulation was thought 
particularly relevant, as 1 molecule of FAD is needed to confer activity to 1 MTOX 
protein.  
 
As has been discussed earlier the cofactor FAD confers activity on the MTOX 
enzyme. For the work undertaken there would be no relevance for the optimisation 
of MTOX production without also considering the implications for cellular FAD 
levels. This simulation underlined the fact that from a finite supply of carbon there 
will always need to be a compromise between any number of carbon sinks present. 
 
Figure 6.2.) Plot showing the predicted flux balance between MTOX and FAD for 2 
different carbon uptake rates. 
 
 
The initial glucose uptake rate of 2.2 mM/g(DCW)/h was the default setting on the 
model system. After analysing HPLC data it was shown that the strains were 
utilising carbon at an average rate 3 times higher, (see Figure 3.2). Fig. 6.2. shows as 
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expected an increase in available carbon with the higher uptake rate and also the 
partitioning of that resource between two carbon sinks. With the higher uptake rate a 
maximum FAD flux of close to 1µM/g(DCW)/h is predicted if MTOX is not 
produced and conversely the model predicts that 0.022mM/g(DCW)/h MTOX is 
achievable if FAD is not produced. As with all linear optimisation methods this 
produces a solution space which contains all possible outcomes in this partitioning 
of resource.  
 
It was then attempted to generate a solution space that included all three variables of 
specific growth rate, flux to FAD and flux to MTOX in one simulation (see Fig. 
6.3).  
 
Figure 6.3) Surface plot of the solution space predicted for BW25113 displaying 
specific growth rate, FAD and MTOX flux.  
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A surface solution space was generated for MTOX production in the cell. It shows 
how, in the model at least, carbon flux can be channelled into cell growth, FAD or 
MTOX production or a combination of the three. Reading off the graph it can be 
seen that a maximal rate of growth will result in an absence of flux to MTOX and 
FAD. Similarly a maximal flux into either of the other two, will cause a zero value 
in the two metabolic endpoints left. In reality this is an impossible result but 
describes the theoretical maximum fluxes achievable under a given set of conditions 
 
However, more interesting is the solution space on the slope. On the flat plane of the 
graph only two fluxes are varying the other being zero. On the slope it can be seen 
that carbon can be sequestered into each of the three endpoints listed, but only 
within a maximal carbon flux overall, constrained by the glucose uptake rate. For 
instance, taking a maximum specific growth rate of 0.323 h-1 and a FAD flux value 
of 0.2 µM/g(DCW)/h, the value of approximately 0.014 mM/g(DCW)/h can be read 
off the z-axis relating to the flux into MTOX production. This demonstrates the 
sectioning of carbon resource into differing sinks. A finite amount of carbon 
(defined by the glucose uptake rate) is sectioned into cell maintenance and growth, 
and specifically the MTOX enzyme being investigated but also the FAD cofactor 
needed for the activity of the enzyme product. 
 
As will be discussed in section 6.5 one of the drawbacks of this simulation is that, by 
definition, the model is static. As mentioned in Chapter 2, for each condition a 
steady state is calculated, therefore this model is not inclusive of the possible 
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utilisation of FAD to produce an active MTOX protein, and any feedback 
mechanism that ensures an adequate supply of FAD for cellular maintenance when 
demands are put on the supply.  
 
It does however give an idea of the maximum value that could be expected from 
experimental work, which will be compared in section 6.4. 
 
 
6.3. Altering carbon flux through specific pathways 
 
Part of the initial rationale for conducting the modelling work was to be able to 
investigate the potential for deletion or up-regulation of genes involved in the FAD 
pathway (see Figure 1.4) without having to create those mutants in the lab. In theory 
many mutants could be investigated with this high-throughput in silico work and 
only the most promising could be cloned and investigated. 
 
Therefore as an extension to the above modelling work FAD levels were again the 
focus in relation to changes in the specific growth rate. However the model was then 
constrained by altering the flux through the riboflavin pathway. As discussed in 
Chapter 1 (section 1.7) it was hypothesised that altering flux through the metabolic 
pathways downstream of riboflavin may alter the production of FAD in the cell. 
Figure 6.4 shows how FAD levels are altered when the carbon flux downstream of 
riboflavin was constrained in the model. 
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Initially the flux down stream of riboflavin was set at zero. This allowed the model 
to compute the solution space with all available carbon being sequestered into either 
FAD or biomass. There were then 3 differing scenarios where the flux downstream 
of riboflavin was increased by 0.25 mM/g(DCW)/h in turn. The effect this loss of 
carbon downstream of riboflavin had on the system is shown below. 
 
 
Figure 6.4) Plot of 4 different simulations showing the effect of altering carbon flux 
through the pathways downstream of riboflavin on FAD flux as a function of specific 
growth rate; with an initial carbon uptake rate of 6.6 mM/g(DCW)/h. 
 
 
 
With no flux of carbon through the pathways downstream of riboflavin the highest 
levels of FAD are achieved, as seen in Figure 6.4.  The graph also shows that 
increasing the specific growth rate reduces the amount of carbon available for FAD 
production and the flux decreases.  It is thought that this scenario could represent a 
mutant strain after the deletion of both cobB and cobT genes, however this would 
render the resulting double mutant auxotrophic for vitamin B12, whereas reductions 
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in flux downstream of riboflavin caused by the deletion of either gene in isolation 
may cause a reduction in flux through the pathway significant enough to display an 
effect similar to that seen in the Figure 6.4. This was seen in the experimental work 
where FAD concentration and subsequently MTOX concentration increased when 
either of the cob mutants were investigated. It was thought that this reduction in 
carbon flux downstream of riboflavin caused by the cobB and cobT mutants allowed 
for accumulation of FAD and therefore an increased level of activity in the MTOX 
enzyme. The difference seen between the two cob mutants is discussed in Chapter 5 
Section 11. 
 
When the flux downstream of riboflavin was increased, a subsequent drop in the 
potential FAD production rate was observed. Again this is an expected result as it 
has been shown in Figure 6.3 that when dealing with the model data a finite amount 
of carbon flux is available for all sources. Above, it is shown that potentially 
lowering the activity of the enzymes, or using mutations to delete them altogether, 
could have a dramatic effect on the level of intracellular FAD and therefore may 
allow a greater proportion of MTOX protein molecules to be made active via 
binding to FAD. As previously mentioned this simulation does not allow for any 
recycling of metabolites in the cell or any feedback mechanisms to replenish 
depleting levels of riboflavin, FMN or FAD. The limitation of the model to provide 
this level of detail will be discussed in section 6.5. 
 
 
Chapter 6:  Constraint based modelling for MTOX strains  
 132 
6.4. Comparison of model predictions with experimental data 
 
To allow comparison between actual experimental values and those generated by the 
metabolic model it was necessary to convert absolute values over the time course of 
fermentation into flux values as described in Chapter 2. These values could then be 
directly compared with the model predictions obtained.  
 
Based on the experimental data shown in chapter 5 section 9 the average flux over a 
7 hour fermentation period of a BW25113 culture for MTOX was 0.008 ± 9.6 x 10-3 
mM/g (DCW)/h and 0.03 ± 2.7 x 10-3µM/g (DCW)/h for FAD.  
 
Compared to the values shown in the figures 6.2. and 6.3 for MTOX production, 
these are as expected. Figure 6.1, shows a value for MTOX production of 0.008 to 
be close to the centre of the expected range but also equates to a growth rate much 
lower than seen experimentally, approximately 0.29 h-1. Investigating figure 6.2.2, 
again the MTOX value is close to the middle of the range equating to a FAD flux of 
0.55 µM/g (DCW)/h. Finally using figure 6.3 the protein flux is again in the centre 
of the solution space but seems to equate to a lower range of values for FAD flux 
and growth rate than perhaps expected. 
 
For FAD however the values calculated from the model seem much higher than 
those derived from the experimental data. Only at the extreme end of the solution 
space shown in figure 6.3 are values seen close to those calculated from the 
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experimental data. There may be a number of factors that could explain the 
differences seen between the experimental results and the model predictions. As will 
be discussed in the following section, no FAD recycle or feedback loop can be 
included in the model work as, by definition, the model seeks a steady state for 
FAD, MTOX and Biomass production. Also there was no constraint in the model for 
each molecule of MTOX to have an FAD molecule bound. However, when 
simulations were carried out using the model and requiring 1 molecule of FAD for 
each MTOX molecule produced this simply reduced the amount of FAD linearly 
with the amount of MTOX produced.  
 
Also the model seemed to underestimate the maximum specific growth rate, the 
highest value being 0.539 h-1 compared with the experimentally derived value of 
0.64 h-1. It also seemed that the model overestimates the effect the production of 
MTOX or the supply of FAD would have on growth rate. Similar to the suggested 
reasons for differences in FAD flux it is likely that there are recycles and feedback 
mechanisms to lessen the impact of cofactor supply or protein production on growth 
rate although it is accepted that at high expression levels a certain degree of growth 
limitation will be seen. Whether a more complex model such as that used by 
Edwards and Palsson (Edwards, et al 2001) or the energy balance analysis (EBA) 
method, (Beard et al., 2002) would provide more accurate predictions is unknown. 
 
The development of metabolic networks has over recent years taken two 
complementary directions. A number of researchers have developed much larger 
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models based on the principles of FBA. The most recent constraint based model of 
Palsson’s group now contains over 200 extra genes compared with the model of the 
year 2000 and over 800 more genes than a decade ago (Reed and Palsson, 2003). 
There are also smaller models that attempt to incorporate some facets of regulation 
into the metabolic network such as the regulated model of E.coli central metabolism 
developed by Palsson’s group, (Covert and Palsson, 2002). The EBA model 
mentioned above adds constraints to a metabolic network that are 
thermodynamically feasible, often removing the extreme pathways mentioned earlier 
and therefore shrinking the solution space to include fewer possible outcomes.  
 
The nature of the approach is such that as a model or network becomes more 
complex, including regulatory or feedback information they become smaller and 
more focused on one part of metabolism, (Furusawa et al., 2008; Beard et al., 2002).  
These models could be useful to identify the drawbacks of the larger FBA models 
when focused on specific parts of the pathway, i.e. FAD metabolism and regulation 
but would need to be viewed in the context of a larger but less regulated metabolic 
network.  
 
What is noticed is that the values generated in Figure 6.3 are generally consistent 
with values described in the model network. However due to the lack of regulatory 
constraints each demand on carbon source from one of the three factors used has a 
direct impact on the level of the other two. It is true that the production of a large 
recombinant protein will impose demands on a cellular system but in reality those 
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demands would be met and adapted to unless the level of recombinant protein is 
very high.  
  
6.5. Drawbacks of the model system 
 
As mentioned previously the basis of the constraint-based FBA model is to arrive at 
a steady state solution space for each change to the reaction network or question 
asked of it. Feedback loops therefore, by definition, cannot be modelled in this way, 
as a steady state could not be reached. Little is known about the mechanisms of 
regulation of the riboflavin pathway in bacteria (Vitreschak et. al, 2002) but it is 
thought that a feedback mechanism plays a part in keeping the pool of cofactors (i.e. 
FMN and FAD) at an approximately constant level. Most studies have estimated the 
level of free FAD to be in the region of 3µM at any point in time (Tu, and 
Weissman, 2002). 
 
If a requirement is made to bind one FAD molecule to each MTOX molecule 
produced, the steady state level of FAD is simply reduced in proportion with the 
amount of MTOX produced. Using the model as shown in Figure 6.4, a reduction in 
flux downstream of riboflavin proportionally increases the amount of FAD 
available. In truth this is a very simplified view of cofactor metabolism in the 
bacterial cell. 
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As such the stochiometric reaction network is useful for relatively simple predictions 
of carbon fate. A certain carbon uptake rate can be sequestered into various carbon 
sinks. If however the reaction network is thought to be more complex, a more 
sophisticated model may be needed. 
 
6.6. Summary and Conclusions 
 
The construction and analysis of metabolic networks has drawn much attention in 
the past few years and this section of the work set out to apply such a model to 
determine theoretical values for the production of the MTOX protein, the supply of 
the co-factor, FAD and how these two demands on metabolism would impact on the 
growth rate of the organism. The aim was then to compare values generated using 
the metabolic model with actual experimental data, which is contained in chapter 5. 
 
In constraint-based modeling, stoichiometric, thermodynamic, flux capacity, energy 
preservation and other constraints are used to limit the space of possible flux 
distributions attainable by the metabolic network. Flux balance analysis work, much 
like the study presented here, has been undertaken by many researchers (Reed, et al, 
2003, Förster et al., 2003, Kaufmann et al, 2003) but as discussed above, is limited 
somewhat by its inability to reconstruct dynamic metabolic occurrences.  
 
The work was based around Edwards and Palsson’s E. coli MG1655 reaction 
network, which was then altered to better reflect E. coli BW25113 and appended to 
include the stoichiometric equation for the production of the MTOX protein. 
Following these alterations solution spaces were calculated concentrating on the three 
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variables of FAD and MTOX flux and maximum specific growth rate. 
 
Initially a simplistic view of MTOX production was seen where MTOX flux decreased 
as the growth rate increased. This was built upon by displaying how a rise in carbon 
uptake rate would increase both the potential levels of MTOX and FAD proportionally.  
 
From the data generated describing the relationships between FAD, MTOX and 
specific growth rate a surface solution space was then constructed displaying the 
interactions of the three carbon sinks under scrutiny. 
 
In relation to the deletion mutant work covered in the previous chapter, flux was 
reduced (in Figure 6.4), in the pathway downstream of riboflavin to simulate a 
lowering of flux through this pathway containing the enzymes 
dimethylbenimidazole phosphoribosyltransferase (cobT) and a linked enzyme 
catalysing the deacetylase of acetyl-CoA synthetase (cobB). It was observed that a 
reduction in carbon flux downstream of riboflavin caused an increase in flux to 
FAD, a phenomenon also seen in the in vivo experimental work (see Chapter 5, 
section 5.8). 
 
The comparison of model predictions, with experimental values was, in general, 
successful, with the predictions of MTOX flux being in line with experimental 
figures, as discussed in section 6.4. FAD flux did seem to be overestimated by the 
model after comparison with fermentation data, but this may have been caused by 
the model’s inability to simulate a dynamic system with an active feedback 
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mechanism. A more sophisticated mathematical solution would have to be sought 
with more information about the possible feedback loops in riboflavin pathways 
before accurate predictions could be made. Such models are used but with greatly 
reduced numbers of metabolites and reactions. Often a system is broken into 
constituent pathways such as ethanol, glycerol and carbohydrate production in 
Saccharomyces cerevisiae, (Torres, et al., 1997) and each pathway is optimised in 
isolation but with increased complexity of regulatory/feedback constraints. This can 
be further developed into a small but multi-objective model such as that using power 
law formalism to simultaneously optimize several metabolic responses at one time 
(Vera, 2003).  
 
This approach could potentially be used for the optimization of metabolites such as 
FAD or riboflavin but might be too focused on specific pathways to give relevant 
information about the production of complex proteins or on the growth 
characteristics described earlier. 
 
In general it was shown that accurate predictions can be made by models of 
metabolic systems, which, in terms of carbon flux can give insight into possible 
metabolic engineering solutions. Models have been shown previously to accurately 
predict carbon flux (Edwards et al, 2001; Pramanik & Keasling, 1997) and have also 
been used to predict whether deletions in an organism’s genome would prove fatal 
or not (Sergre,  2002). 
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It is clear from the work presented that the effect of altering flux through specific 
pathways can be investigated and theoretical maximal values calculated for a 
number of carbon endpoints. A more accurate picture of specific pathways could be 
generated but the focus would have to be on a much smaller well-defined system 
where detailed kinetic and regulatory information is known. Little has been written 
about the regulation of the riboflavin pathway, and in fact the information on usual 
cellular concentration of co-factors such as FAD is sparse. Flux balance modelling 
will always give an idea of the maximal potential for the production of the metabolic 
products under scrutiny and may help guide in vivo experimental work. Specific 
pathways could be investigated in more detail but this would rely on more kinetic 
information than currently available and may lose some of the overall picture the 
model developed here portrays. 
 
In the following chapter all experimental work is discussed as a whole with the 
common themes running through the work explored and potential further work 
suggested. 
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7.1. General experimental aim 
 
The general aims for the preceding work were to develop a model system to investigate 
the production of potentially any recombinant protein in an E.coli host. A plasmid 
expression system was utilised to transform differing strains of host with plasmid 
containing the gene of interest.  
 
Initially GFP was chosen due to the ease that it could be detected and quantified, however 
it was realised that little industrial gain would come from a strain capable of over 
expressing GFP.  
 
Once this semi-high throughput system was developed, in collaboration with GSK the 
focus of the study was shifted to N-methyl tryptophan oxidase (MTOX). As discussed in 
Chapter 5, this was not necessarily a protein of great interest but it forms part of a group 
of proteins known as the flavoenzymes. This large group of FAD co-factor requiring 
proteins are known to be involved in a number of cellular processes such as 
bioluminescence, free radical reduction, DNA repair and also apoptosis (Shumyantseva, 
et al., 2004) and therefore made this group an interesting prospect to investigate. 
 
Finally the third part of the work sought to use a metabolic model of E.coli MG1655 and 
investigate the theoretical fluxes of FAD, MTOX and carbon to biomass including how 
each output parameter reacted to changes in the others. It was planned that data generated 
from the model would be compared to experimentally derived values to confirm or 
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disprove the ability of this reaction network model to accurately predict levels of the two 
metabolites and the growth of the host.  
 
 
7.2. Green fluorescent protein expression 
 
The GFP chapter established a baseline for all the work that would follow and also 
investigated the amount of metabolic burden the chosen plasmid vector would impose on 
each host. 
 
Growth profiles were generated for each strain used and differences noted between the 
plasmid free and plasmid carrying strains (both induced with IPTG and uninduced). From 
these profiles maximum specific growth rates were calculated and compared. HPLC 
analysis was undertaken to measure the concentrations of glucose and acetate throughout 
the time course of each fermentation which generated values used to constrain the model 
system, allowed confirmation that the cultures were carbon limited and also gave a 
measure (through the acetate levels) of metabolic stress (Rahman and Shimizu, 2008). 
 
It was suggested that as metabolic load increased so to would the level of acetate 
production. The experimental findings were seen to be broadly in line with this 
hypothesis with the highest rates of acetate production seen in the plasmid carrying 
strains after induction with IPTG. Differences seen however were not statistically 
significant in this case. A second trend was noticed and described in that maximum 
specific growth rate dropped as perceived metabolic load increased. Again, non 
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significant differences were calculated however a clear trend was seen with growth rates 
being highest in the plasmid free strains, lower when these strains were transformed with 
the plasmid vector, and lower still when the protein included in that vector was induced 
and was produced by the cell. 
 
One significant difference was proved when a total protein level of the original strain was 
investigated. The wild type strain produced 1.91 mg/mL of protein after lysis and 
analysis using the Bradford method (see Chapter 2). This increased significantly to 2.30 
mg/mL in the uninduced plasmid carrying strain and then increased (not significantly) to 
2.41 mg/mL post induction. This was initially unexpected as it was thought the main 
difference would be after the induction and transcription of the recombinant protein GFP. 
It was thought that the cells containing puvGFP containing the AmpR gene would be 
constitutively producing β-lactamase conferring antibiotic resistance to the host. At 
approximately 96kDa (Paton et al., 1994), this is much larger than the 27kDa GFP and 
therefore it follows that its production should have a greater affect on cellular protein 
levels than the smaller GFP. 
 
However when observing gels of cellular lysate and fluorescent data it was clear that in 
shake flask cultures, little, or no control was seen over GFP production with, or without 
induction using IPTG. It was then clear as both uninduced and induced cultures were 
producing GFP and β-lactamase there should be no expected difference between levels of 
intra cellular protein in either culture. This result was confirmed when fluorescence 
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profiles were generated showing similar levels of fluorescence for induced and uninduced 
cultures. 
 
Growth parameters from the shake flask cultures were then compared with values 
recorded from 7L stirred tank reactors. With these faster growing cultures significant 
differences were seen in the fluorescence profiles suggesting transcription was under the 
control of the lac promotor. This level of control was then confirmed to be caused by 
faster growing cultures through the use of shake flask experiments using complex media 
rather than minimal M6 (see chapter 4 section 10).  
 
Why this control of expression should be so greatly affected by growth rate of the host 
was unknown, however a theory was suggested that stated plasmid replication is not 
linked to cell division. At slow growth rates relative plasmid copy number was thought to 
increase, this increased the demand for the lac repressor up to a point where the control 
was not able to be generated by the cell. In faster growing cultures (such as those seen in 
the stirred tank reactors and LB shake flasks), this relative copy number increase did not 
occur as cell division was able to keep pace with plasmid replication. This phenomenon 
was seen with both the GFP plasmid and the MTOX expressing construct and was the 
reason for using LB in much of the MTOX shake flask growth experiments. 
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7.3. Evolution of the model system to express MTOX 
As described above a plasmid vector had been developed, capable of expressing a foreign 
protein of choice. There were some issues over control of expression but these were 
thought to be understood and could be accounted for in future work. The developed 
method of parallel low volume shake flasks was then extended to express a co-factor 
dependent flavoprotein, MTOX. 
 
It was discussed that as part of a wider group of flavoproteins this target gave a more 
industrially relevant purpose to the research. The theory being that any information 
gained about the expression of one member of the group may be universally applicable to 
all. 
 
By definition flavoproteins require FAD as a cofactor, conferring activity when bound to 
the enzyme. This target protein allowed a directed approach for the selection of deletion 
mutants sourced from the Keio collection of non-lethal mutants developed by Mori 
(2000) specifically targeting the riboflavin pathway, responsible for the production and 
potentially regulation of the levels of FAD in the cell. 
 
The peroxide assay initially showed the TG1 strain to be a much higher producer of 
MTOX than the strain developed in house and based on the K-12 strain MG1655 (see 
chapter 5.3). However once the assay was developed to include a measure of the active 
and inactive forms of the enzyme, data was generated to suggest the level of MTOX 
expression may be broadly similar in each strain but differences in activity may be due to 
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an ability of TG1 to supply greater amounts of free FAD for the activation of the enzyme 
product. 
 
FAD measurements were therefore taken throughout the time course of a number of 
fermentations and it was shown that prior to induction the TG1 strain did demonstrate a 
significantly higher concentration of free FAD than the comparison strain MG1655. 
 
This confirmed the assumption that investigating FAD cofactor supply by potentially 
altering parts of the riboflavin metabolic pathway could alter the amount of active 
enzyme produced by a host. 
 
What it also suggested, however was the possibility that simply supplementing the 
growth media used for these experiments with riboflavin may increase the amount of 
active enzyme measured without the need for complex alterations to the production 
strain. A number of strains were therefore grown in excess riboflavin but no significant 
increase in enzyme activity was seen (chapter 5.5).  
 
As riboflavin has no inherent biological activity (Vogl et al. 2007) it is known that it 
firstly needs to enter the cell and secondly needs to be converted to FMN or in this case 
FAD to have any affect on the host involved. Whether the result seen was caused by an 
inability of riboflavin to enter the cell in sufficiently high amounts or whether this 
riboflavin could not be converted into FAD/FMN rapidly enough to affect the activity 
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levels of the recombinant protein product is unknown. Some suggestions for future work 
are however discussed below. 
 
Finally therefore mutants derived by Mori (the Keio collection) were used. This 
collection of non-lethal mutants contained a number of targets thought to affect the 
metabolism of riboflavin.  
 
The three mutants chosen were cobB and cobT, both downstream of riboflavin the 
rationale behind their choice being that a decrease in the carbon flux downstream of 
riboflavin may affect the level of cellular riboflavin and ultimately the level of FAD 
available in the cell. And also appA, a gene coding for the enzyme governing the back 
conversion of FMN to riboflavin, again the rationale being the possibility of lowering 
carbon flux away from FAD may increase its relative abundance in the cell. 
 
It was seen that all 6 strains initially displayed similar growth profiles and also produced 
largely similar amounts of the MTOX protein (see chapter 5.7). Two groups were 
discovered however in that MG1655 and BW25113 and the appA mutant generated 
noticeable lower amounts of active enzyme (roughly 30% of the total enzyme expressed), 
when compared with the cobT and cobB mutants and the TG1 strain (all displaying 
approximately 70% active protein product). This significant difference showed that 
optimisation for a higher level of enzyme activity was possible as there seemed to be a 
number of strains that could provide high levels of FAD for enzyme activation.  
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When investigating cellular FAD levels for these highly active strains it was observed 
that FAD dropped rapidly soon after induction (as it was being utilised by the 
recombinant protein product) but then rose sharply indicating a strong feedback response. 
It has been discussed earlier that little is known regarding the feedback mechanisms in 
place for control of riboflavin levels however some researchers have suggested the idea 
of a riboswitch (Vitreschak et al, 2004) and others have expanded on the theory to 
suggest transport proteins such as those coded for by ypaA may be expressed under the 
control of such switches and thus control the influx and efflux of riboflavin and its 
associated metabolites across the cell membrane (Vogl et al., 2007). 
 
However also seen was a drop in the level of FAD towards the end of each fermentation 
in the stains showing a high level of enzyme activity suggesting the cell can adapt to a 
certain level of FAD demand but that adaptation draws on a finite pool of FAD (or its 
precursors) and the feedback mechanism will eventually either enable the cell to reach 
equilibrium or cause a failure to supply sufficient FAD for the demands imposed on each 
cell as a whole. 
 
Similarly to the GFP work, a limited number of 5L stirred tank fermentations were 
undertaken in an attempt to replicate some of the findings seen in the small scale shake 
flasks. MG1655, TG1 and the BW25113 cobT mutant were used all carrying the 
designed plasmid pQR498. When compared with data generated from shake flask 
cultures it was clear similar patterns were obtained (see Chapter 5.10). Mean specific 
activity (stated in dimensionless units) of the MTOX protein for TG1 was the highest 
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observed returning a value of 10.55 followed by the cobT mutant which generated a 
value of 8.43. The ‘wild type’ MG1655 only produced a specific activity of 3.78. These 
values matched closely with those found in the earlier work with the strains returning 
values of 10.29, 8.05 and 3.69 respectively. 
 
Cellular FAD levels also appeared to be higher in the stirred tank reactors for reasons that 
are discussed in section 5.10. It also seems that MTOX activity is not solely dependant on 
the amount of FAD available in the cell but the amount of that FAD that is available for 
binding to the protein. It would seem that this is strain specific but reasons for this are 
currently unknown. 
 
The conclusion of the MTOX experimental work was that levels of active flavoproteins 
can be increased in cell cultures either by the selection of a strain known to maintain a 
high cellular FAD concentration or to engineer the metabolism of a host in such a way 
that pathways downstream of riboflavin are restricted and an increase in the supply of 
riboflavin, FMN and FAD is possible. Future work based on these observations is 
included at the end of this chapter. 
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7.4. Constraint based modelling and its relevance to the investigational work 
 
To add a third dimension to the work carried out, a model was utilised consisting of a 
large number of reactions in the metabolism of E. coli. As stated previously a total of 695 
genes and 720 reactions based on the originally chosen host strain MG1655 were 
included in this reaction network (Palsson et al., 1997).  
 
Metabolic modelling is becoming more prevalent as it presents opportunities to screen a 
number of mutations or metabolic constraints in silico and thus generating results far 
quicker than possible with in vitro work whist also giving a deeper understanding of the 
interplay of metabolic reactions and its effect on metabolic parameters such as specific 
growth rate or recombinant protein yield.  
 
With this in mind, the work sought to verify previously generated data and therefore 
provide credibility to predictions the model might make over other scenarios. 
 
The model was adapted including known differences between MG1655 and BW25113 
(see Table 2.1) and the stociometric equation for MTOX was also added as a constraint. 
After these additions linear programming was used to search for a solution space 
maximising either growth rate, MTOX production or FAD production (see Chapter 6.2). 
 
Initially pairs of metabolic outputs representing carbon sinks were compared (MTOX vs 
specific growth rate; MTOX vs FAD) and then the data was combined to generate a 
solution space that described the possible interactions of each metabolites concentrations. 
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This ultimately produced a surface plot that was defined by the extreme pathways of 
maximum production of each variable and is shown in Figure 6.3.  
 
Extra constraints were added to demonstrate how a reduction of flux downstream of 
riboflavin might affect cellular FAD levels. This was a rather simplistic view as no 
riboflavin regulation was included in the model, however it did demonstrate how cellular 
FAD concentrations would increase as flux downstream of riboflavin decreased. 
 
Finally, in an attempt to make direct comparisons between the experimentally derived 
and modelled data mean flux over the course of the fermentations were calculated and 
compared with values generated from the model system. 
 
MTOX production as seen in the BW25113 strain appeared to lie directly in the centre of 
the range predicted by the model system whereas FAD levels and specific growth rates 
seemed to be slightly overestimated by the model. It has been mentioned earlier that the 
model system was set up to be a steady state representation of metabolic processes and 
not a dynamic system with multiple inputs and feedback loops as found in vivo. The fact 
that this model cannot account for metabolic regulation may be a reason why it 
underestimates growth rate when the cell is subjected to the pressure of producing a 
recombinant protein. Similarly, although the FAD concentration seen in cultures is within 
the range predicted, the values obtained lie high on the predicted curve generated by the 
model (see figure 6.3). Again, with the model not including any replenishment of FAD or 
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feedback regulation it seems understandable that the model may underestimate the true 
concentration of this compound. 
 
7.5. Future work  
 
Possible extensions to this work could be based around three distinct goals. Initially the 
same experimental model (i.e. MTOX production using an E.coli host) would be used but 
over expression of a number of genes would be investigated rather than the use of 
deletion mutants. Developing strains with up regulated genes would present different 
challenges than have been encountered in previous work described but potential gene 
targets have already been discussed (see section 1.7). When deciding on deletion mutants 
it was seen that the production of riboflavin was controlled directly by the genes ribC and 
ribF. Deletions of these genes would be lethal and therefore are not included in the Keio 
collection previously mentioned here. However their position in the riboflavin pathway 
suggests that up regulation of these may directly affect the level of riboflavin (and 
potentially FAD) contained in the cell. 
 
Another gene that has been mentioned in relation to riboflavin levels is ypaA, one of the 
transport proteins responsible for moving riboflavin across the cell membrane. It was 
discussed in chapter 5.5 that simply enriching the growth medium with riboflavin did 
very little to alter the level of intracellular FAD (as measured by HPLC and MTOX 
activity). Whether using an enriched growth medium and a strain with an up regulated 
ypaA gene would increase these intracellular concentrations is something that could be 
investigated with further work. 
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Secondly, part of the rationale for the move from GFP to MTOX was that the group of 
flavoproteins was thought to have more commercial potential that the fluorescent protein. 
An obvious extension to the work therefore would be to generate a number of similar 
plasmid vectors with the solA gene replaced by genes coding for a number of other 
flavoenzymes. Possible targets would be the closely related flavoprotein monomeric 
sarcosine oxidase (MSOX), also thioredoxin reductase (TrxR) shown to be involved in 
cell division and with a possible number of anti tumour uses. Also the flavoprotein 
cytochrome P450 reductase which would be an interesting target requiring both FMN and 
FAD for activity. Assays, similar to the peroxide assay for MTOX would need to be 
developed but a repeat of all the work carried out in chapter 5 could theoretically be done 
with a number of different protein targets, all requiring FAD for the activation of the 
enzyme product. 
 
The second goal or area of further work would be research into the hypothesis put 
forward for the lack of control of expression displayed by the lac promoter in the plasmid 
constructs in slow growing cultures. It has been suggested that in slow growing cultures 
plasmid copy number increases as cell division does not keep pace with plasmid 
replication. A quantitative PCR assay with forward and reverse primers and a fluorescent 
probe (TaqMan ™) designed to be specific to part of the pQR498 plasmid could be 
developed. Samples from both M6 and LB media shake flask cultures could then be 
tested and the plasmid copy number estimated over the time course of the fermentation 
using a standard curve generated from dilutions of the purified plasmid DNA.  
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Finally, as discussed above it could be investigated whether a more defined model, 
potentially including some form of feedback mechanism could be developed. It is thought 
that far more information would be needed in terms of flux values into and out of this 
system, which may need to be determined experimentally. More information may also 
need to be known about regulation of the interconversion between riboflavin, FAD and 
FMN in the cell, and how this can be altered with as differing demands are put on the 
cell. Currently there is little information known about this and may be a project far 
greater than the scope of work suggested here. 
 
7.6. Summary  
 
In summary, it has been shown that a model system can be created generating an easily 
visualised recombinant protein which could be used for high throughput screening of 
strains/hosts/growth media or mutants designed to over produce various protein products.  
 
This system was altered to focus on a specific protein (MTOX), especially interesting, as 
it is a member of a wider group of proteins, namely the flavoenzymes. As these enzymes 
require FAD to confer activity mutants and strains were investigated to determine the 
level of recombinant protein expression possible and also the level of free FAD available 
intracellular, which could be bound to the enzyme. 
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Finally a constraint based model system was used to generate comparative data 
describing the theoretical maximum levels of FAD, MTOX and rate of growth seen in the 
E. coli host. These values were then compared to experimentally derived figures and 
were shown to be broadly accurate within the known limitations of the model itself. 
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Appendices 
Appendix 1: 
 
Experimental matrix: 
 
A copy of the experimental matrix used to track multiple cell cultures and assays on 
the resulting samples is included overleaf. 
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Strain Plasmid Available? Growth in M6 Growth in LB Total Protein GFP Peroxide HPLC FAD
BW25113 WT Yes Yes Yes Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes N/A Yes Yes
pMEX8 N/A N/A N/A N/A N/A N/A N/A
BW25113 (appA) WT Yes Yes Yes N/A Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes N/A Yes Yes
pMEX8 N/A N/A N/A N/A N/A N/A N/A
BW25113 (cobB) WT Yes Yes Yes N/A Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes N/A Yes Yes
pMEX8 N/A N/A N/A N/A N/A N/A N/A
BW25113 (cobT) WT Yes Yes Yes N/A Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes N/A Yes Yes
pMEX8 N/A N/A N/A N/A N/A N/A N/A
MG1655 WT Yes Yes Yes Yes Yes Yes Yes
pGFPuv Yes Yes Yes Yes Yes N/A N/A
pQR498 Yes Yes Yes Yes N/A Yes Yes
pMEX8 Yes Yes Yes N/A Yes
TG1 WT Yes Yes Yes Yes Yes Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes N/A Yes Yes
pMEX8 Yes Yes Yes N/A Yes
W3110 WT Yes Yes Yes Yes Yes
pGFPuv N/A N/A N/A N/A N/A N/A N/A
pQR498 Yes Yes Yes
pMEX8 N/A N/A N/A N/A N/A N/A N/A
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Appendix 2: 
 
Stociometric equation: 
As mentioned previously one of the restraints imposed upon the reaction network 
model used in Chapter 6 was the stociometric equation for the solA gene (encoding 
the protein MTOX). This included all amino acids in the peptide and also the required 
phosphate for its synthesis. The equation as used, follows: 
 
ala-L   -38 
cys-L  -6 
asp-L  -28 
glu-L  -21 
phe-L  -19 
gly  -34 
his-L  -13 
ile-L  -21 
lys-L  -16 
leu-L  -33 
met-L  -4 
asn-L  -14 
pro-L  -20 
gln-L  -14 
arg-L  -16 
ser-L  -18 
thr-L  -17 
val-L  -22 
tyr-L  -12 
 
atp  -372 
gtp  -372 
 
 
MTOX  1 
adp  372 
gdp  372 
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Appendix 3: 
 
Example Calculations: 
 
1) Maximum specific growth rate 
 
 
 
Figure A.1) Log plot of exponential phase growth of E.coli MG1655 WT, M6 in shake 
flask cultures. 
 
Maximum specific growth rate was calculated using a plot of the natural log(ln) of 
D.C.W. against time of fermentation throughout the exponential phase of growth. 
Linear regression was used to fit a trendline with the slope defining µmax. Clear 
outliers from each curve were removed to improve the coefficient of determination 
(R2) >0.95. 
 
2) Yield calculations: 
 
Yield calculations were performed from a known glucose supply, (4 g/L) or a derived 
acetate final concentration (approx 2.1 g/L, culture dependent). 
 
Both used the value of Xmax (maximum biomass concentration, g/L) depending on 
the culture in question. 
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Therefore:  
 
Yx/glu = Xmax / Glucose concentration 
 
for E.coli strain MG1655, WT, M6,  
 
Yx/glu = 1.72 (g/L) / 4 (g/L) = 0.43 (g/g) 
 
 
Yac/x = Acetate concentration / Xmax 
 
for E.coli strain MG1655, WT, M6,  
 
Yac/x = 2.01 (g/L)/ 1.72 (g/L) = 1.17 (g/g) 
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